Local Coverage Determination (LCD): Noncovered Services (L33777) & (L33296)

 

Contractor Information

Contractor Name Contract Type Contract Number Jurisdiction State(s)

First Coast Service Options, Inc. A and B MAC 09101 - MAC A J - N Florida

First Coast Service Options, Inc. A and B MAC 09102 - MAC B J - N Florida

First Coast Service Options, Inc. A and B MAC 09201 - MAC A J - N Puerto Rico

  Virgin Islands

First Coast Service Options, Inc. A and B MAC 09202 - MAC B J - N Puerto Rico

First Coast Service Options, Inc. A and B MAC 09302 - MAC B J - N Virgin Islands

 

LCD Information

Document Information

 

 

LCD ID

L33777

 

LCD Title

Noncovered Services

 

Proposed LCD in Comment Period

N/A

 

Source Proposed LCD

DL33777

 

A    MA CPT / ADA CDT / AHA NUBC Copyright Statement CPT only copyright 2002-2018 American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services.

The AMA assumes no liability for data contained or not contained herein.

 

The Code on Dental Procedures and Nomenclature (Code) is published in Current Dental Terminology

(CDT). Copyright © American Dental Association. All rights reserved. CDT and CDT-2016 are trademarks of the American Dental Association.

 

Original Effective Date

For services performed on or after 10/01/2015

 

Revision Effective Date

For services performed on or after 03/08/2018

 

Revision Ending Date

N/A

 

Retirement Date

N/A

 

Notice Period Start Date

N/A

 

Notice Period End Date

N/A

 

UB-04 Manual. OFFICIAL UB-04 DATA SPECIFICATIONS

MANUAL, 2014, is copyrighted by American Hospital Association (“AHA”), Chicago, Illinois. No portion of OFFICIAL UB-04 MANUAL may be reproduced, sorted in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior express, written consent of AHA.” Health Forum reserves the right to change the copyright notice from time to time upon written notice to Company.

 

CMS National Coverage Policy

References from CMS National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals are listed throughout the Local Coverage Determination (LCD). NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR 405.560[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See §1869(f)(1)(A)(i) of the Social Security Act.

 

Unless otherwise specified, italicized text represents coverage guidelines from one or more of the following CMS sources:

 

CMS Manual System, Pub. 100-01, Medicare General Information, Eligibility, and Entitlement Manual CMS Manual System, Pub. 100-02, Medicare Benefit Policy Manual

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Transmittal 61, CR 5294, dated November 24, 2006

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Transmittal 67, CR 5530, dated April 6, 2007

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Transmittal 93, CR 6185, dated August 29, 2008

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Transmittal 95, CR 6185, dated September 10, 2008

CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Transmittal 117, CR 6775, dated March 9, 2010

CMS Manual System, Pub. 100-04, Medicare Claims Processing Manual, Transmittal 1258, CR 5614, dated May 29, 2007

CMS Manual System, Pub. 100-04, Medicare Claims Processing Manual, Transmittal 1482, CR 5980, dated March 21, 2008

CMS Manual System, Pub. 100-04, Medicare Claims Processing Manual, Transmittal 1528, CR 6087, dated May 30, 2008

CMS Manual System, Pub. 100-04, Medicare Claims Processing Manual, Transmittal 1930, CR 6775, dated March 9, 2010

CMS Manual System, Pub. 100-04, Medicare Claims Processing Manual, Chapter 30, Section 50 (Advance Beneficiary Notice of Noncoverage [ABN])

CMS Manual System, Pub. 100-08, Medicare Program Integrity Manual, Chapter 13 Change Request 5432, transmittals 64 and 1147, dated January 5, 2007

Change Request 6185, transmittals 95 and 1592, dated September 10, 2008

Change Request 6291, transmittals 1646 and 97, dated December 9, 2008 Change Request 6351, transmittal 1661, dated 01/02/2009

Change Request 6484, transmittal 1748, dated May 29, 2009

Change Request 6492, transmittal 1745, dated May 22, 2009

Change Request 7117, transmittal 2061, dated October 1, 2010

Change Request 7147, transmittal 2045, dated September 10, 2010

Change Request 7443, transmittal 2234, dated May 27, 2011

Change Request 7545, transmittal 2296, dated September 2, 2011

Change Request 7547, transmittal 2305, dated September 15, 2011

Change Request 7610, transmittal 141, dated January 26, 2012

Change Request 8228, transmittal 2664, March 1, 2013

Change Request 8237, transmittal 2662, March 1, 2013

Change Request 8249, transmittal 2693, dated May 2, 2013

Change Request 8317, transmittal 2704, May 17, 2013

Change Request 8338, transmittal 2718, June 7, 2013

Change Request 10236, transmittal 3864, September 15, 2017

Change Request 10117, transmittal 3815, July 28, 2017

 

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

 

A given service or procedure may not be linked to a National Coverage Determination (NCD) or Local Coverage Determination (LCD). Assuming all other requirements of the program are met and absent specific coverage criteria outlined in an LCD or NCD, all procedures or services must meet the medically reasonable and necessary threshold for coverage as demonstrated by the performing provider or attending physician in the official medical record. The Noncovered Services LCD compiles services or procedures that have been addressed by the Medical Policy department as to the medically reasonable and necessary threshold for coverage. Certain services or procedures will not have specific level I or level II HCPCS coding. Such services or procedures would be coded as the appropriate unclassified code. Occasionally services or procedures will be identified by a specific level I (Category I or Category III CPT code) or level II HCPCS code. It is the expectation that physicians and allied providers code to specificity. Payment of a claim is not a coverage statement especially if payable codes were used to bypass the medical review of more specific Level I/Category I unlisted codes or Level I/Category III codes or level II HCPCS codes.

 

In determining if a service or procedure reaches the threshold for coverage, this contractor addresses the quality of the evidence per the program integrity manual in making its recommendation to non-cover a service, pending new information in the public domain. This recommendation is taken through the LCD development process (draft recommendation of noncoverage, 45-day comment period, CAC advisory meeting, open public meeting, finalization, and 45-day notice period). Any interested stakeholder can request a reconsideration of an LCD after the notice period. In the case of the Noncovered Services LCD the stakeholder will receive a list of the articles and related information in the public domain that were addressed by the Medical Policy department in making the noncoverage decision. If the stakeholder has new information based on the evaluation of the list, an LCD reconsideration can be initiated. It is the responsibility of the interested stakeholder to request the evidentiary list from the contractor and to submit the additional articles, data, and related information in support of their request for coverage. The request must meet the LCD reconsideration requirements outlined on the web site.

 

It is not unusual that there will be a paucity of information for an emerging technology or service, and the Medial Policy department may noncover a service as noted in this LCD awaiting information in the public domain on safety and efficacy based on the quality of evidence. Also this contractor may be silent in terms of LCD in regard to a service or procedure (such a procedure or service is not listed in the Noncovered Services LCD or has been removed from the Noncovered Services LCD). A service or procedure not addressed in the Noncovered Services LCD is not a positive coverage statement. Claims for such services assuming all other requirements of the program are met would always need to meet the medically reasonable and necessary threshold for coverage in a prepayment or post payment audit of the official medical record.

 

To summarize, emerging technologies that are billed as either an unlisted procedure code or, when applicable, a Category III CPT or HCPCS code the procedures are addressed as:

 

• Not medically necessary and no coverage per this LCD; or

• Medically necessary per certain criteria as indicated in the development and communication of a separate LCD; or

• Have no positive coverage statement (in other words, no active LCD) and in which case these services as reported by the applicable unlisted procedure code or Category III CPT/HCPCs code would have to meet the regulatory requirements as documented in the medical record. Such services could be audited on pre- payment or post-payment review.

 

Section 1862(a)(1)(A) of the Social Security Act precludes program payment for services not deemed to be medically reasonable and necessary. This section of the Act underpins all Medicare regulations. Any document issued by the Centers for Medicare & Medicaid Services (CMS) or any of its contractors, which contains statements regarding criteria for coverage and payment of any service (e.g., office visits, procedures, diagnostic tests, etc.) has as an underlying assumption that the service must comply with the requirements of

§1862(a)(1)(A). As a consequence, it is incumbent upon such providers to be sure the service they provide is medically necessary, even in the instance where the documentation that proves medical necessity is created and/or housed by an entity other than the performing provider.

 

In order to be covered and reimbursed, an item or service must meet several requirements. It must fall within a defined benefit category, it cannot be excluded from coverage, either by statute or policy, and it must be medically reasonable and necessary. In the absence of a NCD, discretion may be used to establish medical policy, currently known as LCDs. The purpose of this LCD is to create a working list of services and procedures that have been evaluated by the Medical Policy staff, and determined that the services listed below do not meet the reasonable and necessary criteria as defined in Section 1862 (a)(1)(A) of the Social Security Act. LCDs are based on the strongest evidence available. In order of preference, LCDs are based on:

 

Published authoritative evidence derived from definitive randomized clinical trials or other definitive studies, and General acceptance by the medical community (standard of practice), as supported by sound medical evidence based on:

• Scientific data or research studies published in peer-reviewed medical journals;

• Consensus of expert medical opinion (i.e., recognized authorities in the field); or

• Medical opinion derived from consultations with medical associations or other health care experts.

 

Acceptance by individual health care providers, or even a limited group of health care providers, does not indicate general acceptance by the medical community. Testimonials indicating such limited acceptance, and limited case studies distributed by sponsors with financial interest in the outcome, are not sufficient evidence of general acceptance by the medical community. The available published evidence must be considered and its quality shall be evaluated before a conclusion is reached.

 

A service or item is considered to be reasonable and necessary if it is:

• Safe and effective;

• Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:

◦ Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member;

◦ Furnished in a setting appropriate to the patient’s medical needs and condition;

◦ Ordered and furnished by qualified personnel

◦ One that meets, but does not exceed, the patient’s medical need; and

◦ At least as beneficial as an existing and available medically appropriate alternative.

 

NOTE: An Advance Beneficiary Notice (ABN) is required for items and services not covered due to being considered not medically reasonable and necessary. The beneficiary should be thoroughly educated about the benefits and risks of this item or service. If such notice is not given, providers may not shift financial liability for such items or services to beneficiaries should a claim for such items or services be denied by Medicare.

 

The LCD coding guidelines attachment lists the nationally noncovered services/procedures (see link at bottom of LCD).

 

Summary of Evidence

N/A

 

Analysis of Evidence (Rationale for Determination)

N/A

 

Coding Information

 

Bill Type Codes:

 

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

 

N/A

Revenue Codes:

 

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the policy, services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all

 

Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

N/A

CPT/HCPCS Codes Group 1 Paragraph:

Local Noncoverage Decisions Listed Procedure Codes Procedures for Part A and Part B

Note: The below list of noncovered services is not all inclusive.

 

*Codes that contain additional information beyond the CPT descriptor.

 

+Claims for these services will always be reviewed, as they must currently be billed with an unlisted procedure code.

 

++Covered if beneficiary is enrolled in an approved category B investigational device exemption (IDE) study.

 

++Covered if meets CMS coverage with evidence development (CED) criteria.

 

GY Item or service statutorily excluded, does not meet the definition of any Medicare benefit or, for non-Medicare insurers, is not a contract benefit.

 

Procedures for Part A and Part B

 

0388T++ Transcatheter removal of permanent leadless pacemaker, ventricular

 

0421T++ Transurethral waterjet ablation of prostate, including control of post-operative bleeding, including ultrasound guidance, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included when performed)

 

64568* INCISION FOR IMPLANTATION OF CRANIAL NERVE (EG, VAGUS NERVE) NEUROSTIMULATOR ELECTRODE

ARRAY AND PULSE GENERATOR [when specified as implantation of hypoglossal nerve stimulator].

 

87270* Infectious agent antigen detection by direct fluorescent antibody technique; Chlamydia trachomatis (Not medically reasonable and necessary except when billed with diagnosis Z11.3

87320* Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme

-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple step method; Chlamydia trachomatis (Not medically reasonable and necessary except when billed with diagnosis Z11.3)

 

C1749* Endoscope, retrograde imaging/illumination colonoscopic device (implantable); e.g. Third Eye Retroscope®

 

C9727* Insertion of implants into the soft palate; minimum of three implants (Palatal implants [Pillar™])

Group 1 Codes:

20985 COMPUTER-ASSISTED SURGICAL NAVIGATIONAL PROCEDURE FOR MUSCULOSKELETAL PROCEDURES, IMAGE-LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

21073 MANIPULATION OF TEMPOROMANDIBULAR JOINT(S) (TMJ), THERAPEUTIC, REQUIRING AN ANESTHESIA SERVICE (IE, GENERAL OR MONITORED ANESTHESIA CARE)

22586 ARTHRODESIS, PRE-SACRAL INTERBODY TECHNIQUE, INCLUDING DISC SPACE PREPARATION,

DISCECTOMY, WITH POSTERIOR INSTRUMENTATION, WITH IMAGE GUIDANCE, INCLUDES BONE GRAFT WHEN PERFORMED, L5-S1 INTERSPACE

32994 ABLATION THERAPY FOR REDUCTION OR ERADICATION OF 1 OR MORE PULMONARY TUMOR(S)

INCLUDING PLEURA OR CHEST WALL WHEN INVOLVED BY TUMOR EXTENSION, PERCUTANEOUS, INCLUDING IMAGING GUIDANCE WHEN PERFORMED, UNILATERAL; CRYOABLATION

 

41530 SUBMUCOSAL ABLATION OF THE TONGUE BASE, RADIOFREQUENCY, 1 OR MORE SITES, PER SESSION

43201 ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE

43236 ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL

INJECTION(S), ANY SUBSTANCE

43241 ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF

INTRALUMINAL TUBE OR CATHETER

43257 ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DELIVERY OF THERMAL ENERGY TO THE MUSCLE OF LOWER ESOPHAGEAL SPHINCTER AND/OR GASTRIC CARDIA,

FOR TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

43499 UNLISTED PROCEDURE, ESOPHAGUS

43284 LAPAROSCOPY, SURGICAL, ESOPHAGEAL SPHINCTER AUGMENTATION PROCEDURE, PLACEMENT OF SPHINCTER AUGMENTATION DEVICE (IE, MAGNETIC BAND), INCLUDING CRUROPLASTY WHEN

PERFORMED

43285 REMOVAL OF ESOPHAGEAL SPHINCTER AUGMENTATION DEVICE

46601 ANOSCOPY; DIAGNOSTIC, WITH HIGH-RESOLUTION MAGNIFICATION (HRA) (EG, COLPOSCOPE, OPERATING MICROSCOPE) AND CHEMICAL AGENT ENHANCEMENT, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED

46607 ANOSCOPY; WITH HIGH-RESOLUTION MAGNIFICATION (HRA) (EG, COLPOSCOPE, OPERATING MICROSCOPE) AND CHEMICAL AGENT ENHANCEMENT, WITH BIOPSY, SINGLE OR MULTIPLE

46707 REPAIR OF ANORECTAL FISTULA WITH PLUG (EG, PORCINE SMALL INTESTINE SUBMUCOSA [SIS])

58674 LAPAROSCOPY, SURGICAL, ABLATION OF UTERINE FIBROID(S) INCLUDING INTRAOPERATIVE ULTRASOUND GUIDANCE AND MONITORING, RADIOFREQUENCY

81504 ONCOLOGY (TISSUE OF ORIGIN), MICROARRAY GENE EXPRESSION PROFILING OF > 2000 GENES, UTILIZING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, ALGORITHM REPORTED AS TISSUE SIMILARITY SCORES

82016 ACYLCARNITINES; QUALITATIVE, EACH SPECIMEN

82017 ACYLCARNITINES; QUANTITATIVE, EACH SPECIMEN

83987 PH; EXHALED BREATH CONDENSATE

84134 PREALBUMIN

86316 IMMUNOASSAY FOR TUMOR ANTIGEN, OTHER ANTIGEN, QUANTITATIVE (EG, CA 50, 72-4, 549), EACH

86343 LEUKOCYTE HISTAMINE RELEASE TEST (LHR)

87084 CULTURE, PRESUMPTIVE, PATHOGENIC ORGANISMS, SCREENING ONLY; WITH COLONY ESTIMATION FROM DENSITY CHART

87471 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); BARTONELLA HENSELAE AND BARTONELLA QUINTANA, AMPLIFIED PROBE TECHNIQUE

87472 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); BARTONELLA HENSELAE AND BARTONELLA QUINTANA, QUANTIFICATION

87475 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); BORRELIA BURGDORFERI, DIRECT PROBE TECHNIQUE

87482 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CANDIDA SPECIES,

QUANTIFICATION

87485 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CHLAMYDIA PNEUMONIAE, DIRECT PROBE TECHNIQUE

87487 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CHLAMYDIA PNEUMONIAE, QUANTIFICATION

87492 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); CHLAMYDIA TRACHOMATIS, QUANTIFICATION

87511 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); GARDNERELLA VAGINALIS,

AMPLIFIED PROBE TECHNIQUE

87512 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); GARDNERELLA VAGINALIS, QUANTIFICATION

87520 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HEPATITIS C, DIRECT PROBE TECHNIQUE

87525 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HEPATITIS G, DIRECT PROBE

TECHNIQUE

87526 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HEPATITIS G, AMPLIFIED PROBE TECHNIQUE

87527 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HEPATITIS G, QUANTIFICATION

87531 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HERPES VIRUS-6, DIRECT PROBE TECHNIQUE

87532 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HERPES VIRUS-6, AMPLIFIED PROBE TECHNIQUE

87533 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); HERPES VIRUS-6, QUANTIFICATION

87540 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); LEGIONELLA PNEUMOPHILA,

DIRECT PROBE TECHNIQUE

87541 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); LEGIONELLA PNEUMOPHILA, AMPLIFIED PROBE TECHNIQUE

 

87542 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); LEGIONELLA PNEUMOPHILA, QUANTIFICATION

87557 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); MYCOBACTERIA TUBERCULOSIS, QUANTIFICATION

87562 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); MYCOBACTERIA AVIUM- INTRACELLULARE, QUANTIFICATION

87580 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); MYCOPLASMA PNEUMONIAE, DIRECT PROBE TECHNIQUE

87581 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); MYCOPLASMA PNEUMONIAE,

AMPLIFIED PROBE TECHNIQUE

87582 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); MYCOPLASMA PNEUMONIAE, QUANTIFICATION

87592 INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); NEISSERIA GONORRHOEAE, QUANTIFICATION

90620 MENINGOCOCCAL RECOMBINANT PROTEIN AND OUTER MEMBRANE VESICLE VACCINE, SEROGROUP B (MENB-4C), 2 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90621 MENINGOCOCCAL RECOMBINANT LIPOPROTEIN VACCINE, SEROGROUP B (MENB-FHBP), 2 OR 3

DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90644 MENINGOCOCCAL CONJUGATE VACCINE, SEROGROUPS C & Y AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB-MENCY), 4 DOSE SCHEDULE, WHEN ADMINISTERED TO CHILDREN 6

WEEKS-18 MONTHS OF AGE, FOR INTRAMUSCULAR USE

90650 HUMAN PAPILLOMAVIRUS VACCINE, TYPES 16, 18, BIVALENT (2VHPV), 3 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90681 ROTAVIRUS VACCINE, HUMAN, ATTENUATED (RV1), 2 DOSE SCHEDULE, LIVE, FOR ORAL USE

91112 GASTROINTESTINAL TRANSIT AND PRESSURE MEASUREMENT, STOMACH THROUGH COLON, WIRELESS CAPSULE, WITH INTERPRETATION AND REPORT

92145 CORNEAL HYSTERESIS DETERMINATION, BY AIR IMPULSE STIMULATION, UNILATERAL OR BILATERAL, WITH INTERPRETATION AND REPORT

92227 REMOTE IMAGING FOR DETECTION OF RETINAL DISEASE (EG, RETINOPATHY IN A PATIENT WITH DIABETES) WITH ANALYSIS AND REPORT UNDER PHYSICIAN SUPERVISION, UNILATERAL OR BILATERAL

92228 REMOTE IMAGING FOR MONITORING AND MANAGEMENT OF ACTIVE RETINAL DISEASE (EG, DIABETIC RETINOPATHY) WITH PHYSICIAN REVIEW, INTERPRETATION AND REPORT, UNILATERAL OR BILATERAL

93050 ARTERIAL PRESSURE WAVEFORM ANALYSIS FOR ASSESSMENT OF CENTRAL ARTERIAL PRESSURES, INCLUDES OBTAINING WAVEFORM(S), DIGITIZATION AND APPLICATION OF NONLINEAR MATHEMATICAL TRANSFORMATIONS TO DETERMINE CENTRAL ARTERIAL PRESSURES AND AUGMENTATION INDEX, WITH INTERPRETATION AND REPORT, UPPER EXTREMITY ARTERY,

NON-INVASIVE

93702 BIOIMPEDANCE SPECTROSCOPY (BIS), EXTRACELLULAR FLUID ANALYSIS FOR LYMPHEDEMA ASSESSMENT(S)

96932 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF SKIN; IMAGE ACQUISITION ONLY, FIRST LESION

96933 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF SKIN; INTERPRETATION AND REPORT ONLY, FIRST LESION

96934 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF

SKIN; IMAGE ACQUISITION AND INTERPRETATION AND REPORT, EACH ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

96935 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF

SKIN; IMAGE ACQUISITION ONLY, EACH ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

96936 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF

SKIN; INTERPRETATION AND REPORT ONLY, EACH ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

99605 MEDICATION THERAPY MANAGEMENT SERVICE(S) PROVIDED BY A PHARMACIST, INDIVIDUAL,

FACE-TO-FACE WITH PATIENT, WITH ASSESSMENT AND INTERVENTION IF PROVIDED; INITIAL 15 MINUTES, NEW PATIENT

99606 MEDICATION THERAPY MANAGEMENT SERVICE(S) PROVIDED BY A PHARMACIST, INDIVIDUAL,

FACE-TO-FACE WITH PATIENT, WITH ASSESSMENT AND INTERVENTION IF PROVIDED; INITIAL 15 MINUTES, ESTABLISHED PATIENT

99607 MEDICATION THERAPY MANAGEMENT SERVICE(S) PROVIDED BY A PHARMACIST, INDIVIDUAL,

 

 FACE-TO-FACE WITH PATIENT, WITH ASSESSMENT AND INTERVENTION IF PROVIDED; EACH ADDITIONAL 15 MINUTES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY SERVICE)

C1830 POWERED BONE MARROW BIOPSY NEEDLE

C2624 IMPLANTABLE WIRELESS PULMONARY ARTERY PRESSURE SENSOR WITH DELIVERY CATHETER, INCLUDING ALL SYSTEM COMPONENTS

C9734 FOCUSED ULTRASOUND ABLATION/THERAPEUTIC INTERVENTION, OTHER THAN UTERINE

LEIOMYOMATA, WITH MAGNETIC RESONANCE (MR) GUIDANCE

G0455 PREPARATION WITH INSTILLATION OF FECAL MICROBIOTA BY ANY METHOD, INCLUDING ASSESSMENT OF DONOR SPECIMEN

0042T CEREBRAL PERFUSION ANALYSIS USING COMPUTED TOMOGRAPHY WITH CONTRAST ADMINISTRATION, INCLUDING POST-PROCESSING OF PARAMETRIC MAPS WITH DETERMINATION OF CEREBRAL BLOOD FLOW, CEREBRAL BLOOD VOLUME, AND MEAN TRANSIT TIME

0054T COMPUTER-ASSISTED MUSCULOSKELETAL SURGICAL NAVIGATIONAL ORTHOPEDIC PROCEDURE, WITH IMAGE-GUIDANCE BASED ON FLUOROSCOPIC IMAGES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0055T COMPUTER-ASSISTED MUSCULOSKELETAL SURGICAL NAVIGATIONAL ORTHOPEDIC PROCEDURE, WITH IMAGE-GUIDANCE BASED ON CT/MRI IMAGES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0111T LONG-CHAIN (C20-22) OMEGA-3 FATTY ACIDS IN RED BLOOD CELL (RBC) MEMBRANES

0159T COMPUTER-AIDED DETECTION, INCLUDING COMPUTER ALGORITHM ANALYSIS OF MRI IMAGE DATA FOR LESION DETECTION/CHARACTERIZATION, PHARMACOKINETIC ANALYSIS, WITH

FURTHER PHYSICIAN REVIEW FOR INTERPRETATION, BREAST MRI (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0184T EXCISION OF RECTAL TUMOR, TRANSANAL ENDOSCOPIC MICROSURGICAL APPROACH (IE, TEMS), INCLUDING MUSCULARIS PROPRIA (IE, FULL THICKNESS)

0190T PLACEMENT OF INTRAOCULAR RADIATION SOURCE APPLICATOR (LIST SEPARATELY IN ADDITION

TO PRIMARY PROCEDURE)

0195T ARTHRODESIS, PRE-SACRAL INTERBODY TECHNIQUE, DISC SPACE PREPARATION, DISCECTOMY, WITHOUT INSTRUMENTATION, WITH IMAGE GUIDANCE, INCLUDES BONE GRAFT WHEN

PERFORMED; L5-S1 INTERSPACE

0196T ARTHRODESIS, PRE-SACRAL INTERBODY TECHNIQUE, DISC SPACE PREPARATION, DISCECTOMY, WITHOUT INSTRUMENTATION, WITH IMAGE GUIDANCE, INCLUDES BONE GRAFT WHEN

PERFORMED; L4-L5 INTERSPACE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0198T MEASUREMENT OF OCULAR BLOOD FLOW BY REPETITIVE INTRAOCULAR PRESSURE SAMPLING,

WITH INTERPRETATION AND REPORT

0205T INTRAVASCULAR CATHETER-BASED CORONARY VESSEL OR GRAFT SPECTROSCOPY (EG, INFRARED) DURING DIAGNOSTIC EVALUATION AND/OR THERAPEUTIC INTERVENTION INCLUDING

IMAGING SUPERVISION, INTERPRETATION, AND REPORT, EACH VESSEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0206T COMPUTERIZED DATABASE ANALYSIS OF MULTIPLE CYCLES OF DIGITIZED CARDIAC ELECTRICAL DATA FROM TWO OR MORE ECG LEADS, INCLUDING TRANSMISSION TO A REMOTE CENTER,

APPLICATION OF MULTIPLE NONLINEAR MATHEMATICAL TRANSFORMATIONS, WITH CORONARY ARTERY OBSTRUCTION SEVERITY ASSESSMENT

0207T EVACUATION OF MEIBOMIAN GLANDS, AUTOMATED, USING HEAT AND INTERMITTENT PRESSURE,

UNILATERAL

0208T PURE TONE AUDIOMETRY (THRESHOLD), AUTOMATED; AIR ONLY

0209T PURE TONE AUDIOMETRY (THRESHOLD), AUTOMATED; AIR AND BONE

0210T SPEECH AUDIOMETRY THRESHOLD, AUTOMATED;

0211T SPEECH AUDIOMETRY THRESHOLD, AUTOMATED; WITH SPEECH RECOGNITION

0212T COMPREHENSIVE AUDIOMETRY THRESHOLD EVALUATION AND SPEECH RECOGNITION (0209T, 0211T COMBINED), AUTOMATED

0213T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, CERVICAL OR THORACIC; SINGLE LEVEL

0214T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, CERVICAL OR THORACIC; SECOND LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0215T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, CERVICAL OR THORACIC; THIRD AND ANY ADDITIONAL LEVEL(S) (LIST SEPARATELY IN ADDITION TO CODE FOR

 

 PRIMARY PROCEDURE)

0216T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, LUMBAR OR SACRAL; SINGLE LEVEL

0217T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, LUMBAR OR SACRAL; SECOND LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0218T INJECTION(S), DIAGNOSTIC OR THERAPEUTIC AGENT, PARAVERTEBRAL FACET (ZYGAPOPHYSEAL) JOINT (OR NERVES INNERVATING THAT JOINT) WITH ULTRASOUND GUIDANCE, LUMBAR OR SACRAL; THIRD AND ANY ADDITIONAL LEVEL(S) (LIST SEPARATELY IN ADDITION TO CODE FOR

PRIMARY PROCEDURE)

0219T PLACEMENT OF A POSTERIOR INTRAFACET IMPLANT(S), UNILATERAL OR BILATERAL, INCLUDING IMAGING AND PLACEMENT OF BONE GRAFT(S) OR SYNTHETIC DEVICE(S), SINGLE LEVEL;

CERVICAL

0220T PLACEMENT OF A POSTERIOR INTRAFACET IMPLANT(S), UNILATERAL OR BILATERAL, INCLUDING IMAGING AND PLACEMENT OF BONE GRAFT(S) OR SYNTHETIC DEVICE(S), SINGLE LEVEL;

THORACIC

0221T PLACEMENT OF A POSTERIOR INTRAFACET IMPLANT(S), UNILATERAL OR BILATERAL, INCLUDING IMAGING AND PLACEMENT OF BONE GRAFT(S) OR SYNTHETIC DEVICE(S), SINGLE LEVEL; LUMBAR

0222T PLACEMENT OF A POSTERIOR INTRAFACET IMPLANT(S), UNILATERAL OR BILATERAL, INCLUDING IMAGING AND PLACEMENT OF BONE GRAFT(S) OR SYNTHETIC DEVICE(S), SINGLE LEVEL; EACH ADDITIONAL VERTEBRAL SEGMENT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY

PROCEDURE)

0228T INJECTION(S), ANESTHETIC AGENT AND/OR STEROID, TRANSFORAMINAL EPIDURAL, WITH ULTRASOUND GUIDANCE, CERVICAL OR THORACIC; SINGLE LEVEL

0229T INJECTION(S), ANESTHETIC AGENT AND/OR STEROID, TRANSFORAMINAL EPIDURAL, WITH ULTRASOUND GUIDANCE, CERVICAL OR THORACIC; EACH ADDITIONAL LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0230T INJECTION(S), ANESTHETIC AGENT AND/OR STEROID, TRANSFORAMINAL EPIDURAL, WITH ULTRASOUND GUIDANCE, LUMBAR OR SACRAL; SINGLE LEVEL

0231T INJECTION(S), ANESTHETIC AGENT AND/OR STEROID, TRANSFORAMINAL EPIDURAL, WITH ULTRASOUND GUIDANCE, LUMBAR OR SACRAL; EACH ADDITIONAL LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0232T INJECTION(S), PLATELET RICH PLASMA, ANY SITE, INCLUDING IMAGE GUIDANCE, HARVESTING AND PREPARATION WHEN PERFORMED

0234T TRANSLUMINAL PERIPHERAL ATHERECTOMY, OPEN OR PERCUTANEOUS, INCLUDING

RADIOLOGICAL SUPERVISION AND INTERPRETATION; RENAL ARTERY

0235T TRANSLUMINAL PERIPHERAL ATHERECTOMY, OPEN OR PERCUTANEOUS, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; VISCERAL ARTERY (EXCEPT RENAL), EACH

VESSEL

0236T TRANSLUMINAL PERIPHERAL ATHERECTOMY, OPEN OR PERCUTANEOUS, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; ABDOMINAL AORTA

0237T TRANSLUMINAL PERIPHERAL ATHERECTOMY, OPEN OR PERCUTANEOUS, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; BRACHIOCEPHALIC TRUNK AND BRANCHES, EACH VESSEL

0238T TRANSLUMINAL PERIPHERAL ATHERECTOMY, OPEN OR PERCUTANEOUS, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; ILIAC ARTERY, EACH VESSEL

0253T INSERTION OF ANTERIOR SEGMENT AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, INTERNAL APPROACH, INTO THE SUPRACHOROIDAL SPACE

0263T INTRAMUSCULAR AUTOLOGOUS BONE MARROW CELL THERAPY, WITH PREPARATION OF HARVESTED CELLS, MULTIPLE INJECTIONS, ONE LEG, INCLUDING ULTRASOUND GUIDANCE, IF

PERFORMED; COMPLETE PROCEDURE INCLUDING UNILATERAL OR BILATERAL BONE MARROW HARVEST

0264T INTRAMUSCULAR AUTOLOGOUS BONE MARROW CELL THERAPY, WITH PREPARATION OF HARVESTED CELLS, MULTIPLE INJECTIONS, ONE LEG, INCLUDING ULTRASOUND GUIDANCE, IF

PERFORMED; COMPLETE PROCEDURE EXCLUDING BONE MARROW HARVEST

0265T INTRAMUSCULAR AUTOLOGOUS BONE MARROW CELL THERAPY, WITH PREPARATION OF HARVESTED CELLS, MULTIPLE INJECTIONS, ONE LEG, INCLUDING ULTRASOUND GUIDANCE, IF PERFORMED; UNILATERAL OR BILATERAL BONE MARROW HARVEST ONLY FOR INTRAMUSCULAR AUTOLOGOUS BONE MARROW CELL THERAPY

0274T PERCUTANEOUS LAMINOTOMY/LAMINECTOMY (INTERLAMINAR APPROACH) FOR DECOMPRESSION

 

 OF NEURAL ELEMENTS, (WITH OR WITHOUT LIGAMENTOUS RESECTION, DISCECTOMY, FACETECTOMY AND/OR FORAMINOTOMY), ANY METHOD, UNDER INDIRECT IMAGE GUIDANCE (EG, FLUOROSCOPIC, CT), SINGLE OR MULTIPLE LEVELS, UNILATERAL OR BILATERAL; CERVICAL OR THORACIC

0278T TRANSCUTANEOUS ELECTRICAL MODULATION PAIN REPROCESSING (EG, SCRAMBLER THERAPY), EACH TREATMENT SESSION (INCLUDES PLACEMENT OF ELECTRODES)

0312T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); LAPAROSCOPIC IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY, ANTERIOR AND POSTERIOR VAGAL TRUNKS ADJACENT

TO ESOPHAGOGASTRIC JUNCTION (EGJ), WITH IMPLANTATION OF PULSE GENERATOR, INCLUDES PROGRAMMING

0313T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); LAPAROSCOPIC REVISION OR REPLACEMENT OF VAGAL TRUNK NEUROSTIMULATOR ELECTRODE ARRAY, INCLUDING CONNECTION TO EXISTING PULSE GENERATOR

0314T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); LAPAROSCOPIC REMOVAL OF VAGAL TRUNK NEUROSTIMULATOR ELECTRODE ARRAY AND PULSE GENERATOR

0315T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); REMOVAL OF PULSE GENERATOR

0316T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); REPLACEMENT OF PULSE GENERATOR

0317T VAGUS NERVE BLOCKING THERAPY (MORBID OBESITY); NEUROSTIMULATOR PULSE GENERATOR ELECTRONIC ANALYSIS, INCLUDES REPROGRAMMING WHEN PERFORMED

0331T MYOCARDIAL SYMPATHETIC INNERVATION IMAGING, PLANAR QUALITATIVE AND QUANTITATIVE ASSESSMENT;

0332T MYOCARDIAL SYMPATHETIC INNERVATION IMAGING, PLANAR QUALITATIVE AND QUANTITATIVE ASSESSMENT; WITH TOMOGRAPHIC SPECT

0333T VISUAL EVOKED POTENTIAL, SCREENING OF VISUAL ACUITY, AUTOMATED, WITH REPORT

0335T EXTRA-OSSEOUS SUBTALAR JOINT IMPLANT FOR TALOTARSAL STABILIZATION

0337T ENDOTHELIAL FUNCTION ASSESSMENT, USING PERIPHERAL VASCULAR RESPONSE TO REACTIVE

HYPEREMIA, NON-INVASIVE (EG, BRACHIAL ARTERY ULTRASOUND, PERIPHERAL ARTERY TONOMETRY), UNILATERAL OR BILATERAL

0341T QUANTITATIVE PUPILLOMETRY WITH INTERPRETATION AND REPORT, UNILATERAL OR BILATERAL

0342T THERAPEUTIC APHERESIS WITH SELECTIVE HDL DELIPIDATION AND PLASMA REINFUSION

0346T ULTRASOUND, ELASTOGRAPHY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0347T PLACEMENT OF INTERSTITIAL DEVICE(S) IN BONE FOR RADIOSTEREOMETRIC ANALYSIS (RSA)

0348T RADIOLOGIC EXAMINATION, RADIOSTEREOMETRIC ANALYSIS (RSA); SPINE, (INCLUDES CERVICAL, THORACIC AND LUMBOSACRAL, WHEN PERFORMED)

0349T RADIOLOGIC EXAMINATION, RADIOSTEREOMETRIC ANALYSIS (RSA); UPPER EXTREMITY(IES), (INCLUDES SHOULDER, ELBOW, AND WRIST, WHEN PERFORMED)

0350T RADIOLOGIC EXAMINATION, RADIOSTEREOMETRIC ANALYSIS (RSA); LOWER EXTREMITY(IES), (INCLUDES HIP, PROXIMAL FEMUR, KNEE, AND ANKLE, WHEN PERFORMED)

0351T OPTICAL COHERENCE TOMOGRAPHY OF BREAST OR AXILLARY LYMPH NODE, EXCISED TISSUE, EACH SPECIMEN; REAL-TIME INTRAOPERATIVE

0352T OPTICAL COHERENCE TOMOGRAPHY OF BREAST OR AXILLARY LYMPH NODE, EXCISED TISSUE,

EACH SPECIMEN; INTERPRETATION AND REPORT, REAL-TIME OR REFERRED

0353T OPTICAL COHERENCE TOMOGRAPHY OF BREAST, SURGICAL CAVITY; REAL-TIME INTRAOPERATIVE

0354T OPTICAL COHERENCE TOMOGRAPHY OF BREAST, SURGICAL CAVITY; INTERPRETATION AND REPORT, REAL-TIME OR REFERRED

0355T GASTROINTESTINAL TRACT IMAGING, INTRALUMINAL (EG, CAPSULE ENDOSCOPY), COLON, WITH

INTERPRETATION AND REPORT

0356T INSERTION OF DRUG-ELUTING IMPLANT (INCLUDING PUNCTAL DILATION AND IMPLANT REMOVAL WHEN PERFORMED) INTO LACRIMAL CANALICULUS, EACH

0358T BIOELECTRICAL IMPEDANCE ANALYSIS WHOLE BODY COMPOSITION ASSESSMENT, WITH INTERPRETATION AND REPORT

0359T BEHAVIOR IDENTIFICATION ASSESSMENT, BY THE PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, FACE-TO-FACE WITH PATIENT AND CAREGIVER(S), INCLUDES ADMINISTRATION OF STANDARDIZED AND NON-STANDARDIZED TESTS, DETAILED BEHAVIORAL HISTORY, PATIENT OBSERVATION AND CAREGIVER INTERVIEW, INTERPRETATION OF TEST

RESULTS, DISCUSSION OF FINDINGS AND RECOMMENDATIONS WITH THE PRIMARY GUARDIAN(S)/CAREGIVER(S), AND PREPARATION OF REPORT

0360T OBSERVATIONAL BEHAVIORAL FOLLOW-UP ASSESSMENT, INCLUDES PHYSICIAN OR OTHER

QUALIFIED HEALTH CARE PROFESSIONAL DIRECTION WITH INTERPRETATION AND REPORT, ADMINISTERED BY ONE TECHNICIAN; FIRST 30 MINUTES OF TECHNICIAN TIME, FACE-TO-FACE

 

 WITH THE PATIENT

0361T OBSERVATIONAL BEHAVIORAL FOLLOW-UP ASSESSMENT, INCLUDES PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL DIRECTION WITH INTERPRETATION AND REPORT, ADMINISTERED BY ONE TECHNICIAN; EACH ADDITIONAL 30 MINUTES OF TECHNICIAN TIME,

FACE-TO-FACE WITH THE PATIENT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY SERVICE)

0362T EXPOSURE BEHAVIORAL FOLLOW-UP ASSESSMENT, INCLUDES PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL DIRECTION WITH INTERPRETATION AND REPORT, ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL WITH THE ASSISTANCE OF

ONE OR MORE TECHNICIANS; FIRST 30 MINUTES OF TECHNICIAN(S) TIME, FACE-TO-FACE WITH THE PATIENT

0363T EXPOSURE BEHAVIORAL FOLLOW-UP ASSESSMENT, INCLUDES PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL DIRECTION WITH INTERPRETATION AND REPORT, ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL WITH THE ASSISTANCE OF

ONE OR MORE TECHNICIANS; EACH ADDITIONAL 30 MINUTES OF TECHNICIAN(S) TIME, FACE-TO- FACE WITH THE PATIENT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0364T ADAPTIVE BEHAVIOR TREATMENT BY PROTOCOL, ADMINISTERED BY TECHNICIAN, FACE-TO-FACE WITH ONE PATIENT; FIRST 30 MINUTES OF TECHNICIAN TIME

0365T ADAPTIVE BEHAVIOR TREATMENT BY PROTOCOL, ADMINISTERED BY TECHNICIAN, FACE-TO-FACE

WITH ONE PATIENT; EACH ADDITIONAL 30 MINUTES OF TECHNICIAN TIME (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0366T GROUP ADAPTIVE BEHAVIOR TREATMENT BY PROTOCOL, ADMINISTERED BY TECHNICIAN, FACE-

TO-FACE WITH TWO OR MORE PATIENTS; FIRST 30 MINUTES OF TECHNICIAN TIME

0367T GROUP ADAPTIVE BEHAVIOR TREATMENT BY PROTOCOL, ADMINISTERED BY TECHNICIAN, FACE- TO-FACE WITH TWO OR MORE PATIENTS; EACH ADDITIONAL 30 MINUTES OF TECHNICIAN TIME

(LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0368T ADAPTIVE BEHAVIOR TREATMENT WITH PROTOCOL MODIFICATION ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL WITH ONE PATIENT; FIRST 30 MINUTES OF

PATIENT FACE-TO-FACE TIME

0369T ADAPTIVE BEHAVIOR TREATMENT WITH PROTOCOL MODIFICATION ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL WITH ONE PATIENT; EACH ADDITIONAL 30

MINUTES OF PATIENT FACE-TO-FACE TIME (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0370T FAMILY ADAPTIVE BEHAVIOR TREATMENT GUIDANCE, ADMINISTERED BY PHYSICIAN OR OTHER

QUALIFIED HEALTH CARE PROFESSIONAL (WITHOUT THE PATIENT PRESENT)

0371T MULTIPLE-FAMILY GROUP ADAPTIVE BEHAVIOR TREATMENT GUIDANCE, ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL (WITHOUT THE PATIENT

PRESENT)

0372T ADAPTIVE BEHAVIOR TREATMENT SOCIAL SKILLS GROUP, ADMINISTERED BY PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL FACE-TO-FACE WITH MULTIPLE PATIENTS

0373T EXPOSURE ADAPTIVE BEHAVIOR TREATMENT WITH PROTOCOL MODIFICATION REQUIRING TWO OR MORE TECHNICIANS FOR SEVERE MALADAPTIVE BEHAVIOR(S); FIRST 60 MINUTES OF TECHNICIANS' TIME, FACE-TO-FACE WITH PATIENT

0374T EXPOSURE ADAPTIVE BEHAVIOR TREATMENT WITH PROTOCOL MODIFICATION REQUIRING TWO OR MORE TECHNICIANS FOR SEVERE MALADAPTIVE BEHAVIOR(S); EACH ADDITIONAL 30 MINUTES OF TECHNICIANS' TIME FACE-TO-FACE WITH PATIENT (LIST SEPARATELY IN ADDITION

TO CODE FOR PRIMARY PROCEDURE)

0378T VISUAL FIELD ASSESSMENT, WITH CONCURRENT REAL TIME DATA ANALYSIS AND ACCESSIBLE DATA STORAGE WITH PATIENT INITIATED DATA TRANSMITTED TO A REMOTE SURVEILLANCE

CENTER FOR UP TO 30 DAYS; REVIEW AND INTERPRETATION WITH REPORT BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

0379T VISUAL FIELD ASSESSMENT, WITH CONCURRENT REAL TIME DATA ANALYSIS AND ACCESSIBLE DATA STORAGE WITH PATIENT INITIATED DATA TRANSMITTED TO A REMOTE SURVEILLANCE CENTER FOR UP TO 30 DAYS; TECHNICAL SUPPORT AND PATIENT INSTRUCTIONS, SURVEILLANCE,

ANALYSIS, AND TRANSMISSION OF DAILY AND EMERGENT DATA REPORTS AS PRESCRIBED BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

0380T COMPUTER-AIDED ANIMATION AND ANALYSIS OF TIME SERIES RETINAL IMAGES FOR THE MONITORING OF DISEASE PROGRESSION, UNILATERAL OR BILATERAL, WITH INTERPRETATION AND REPORT

0381T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING UP TO 14 DAYS TO ASSESS CHANGES IN HEART RATE AND TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF

 

 DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

0382T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING UP TO 14 DAYS TO ASSESS CHANGES IN HEART RATE AND TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS

WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, REVIEW AND INTERPRETATION ONLY

0383T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING FROM 15 TO 30 DAYS TO ASSESS CHANGES IN HEART RATE TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS

WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

0384T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING FROM 15 TO 30 DAYS TO ASSESS CHANGES IN HEART RATE TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH

CARE PROFESSIONAL, REVIEW AND INTERPRETATION ONLY

0385T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING MORE THAN 30 DAYS TO ASSESS CHANGES IN HEART RATE TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS

WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

0386T EXTERNAL HEART RATE AND 3-AXIS ACCELEROMETER DATA RECORDING MORE THAN 30 DAYS TO ASSESS CHANGES IN HEART RATE TO MONITOR MOTION ANALYSIS FOR THE PURPOSES OF DIAGNOSING NOCTURNAL EPILEPSY SEIZURE EVENTS; INCLUDES REPORT, SCANNING ANALYSIS

WITH REPORT, REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, REVIEW AND INTERPRETATION ONLY

0396T INTRA-OPERATIVE USE OF KINETIC BALANCE SENSOR FOR IMPLANT STABILITY DURING KNEE

REPLACEMENT ARTHROPLASTY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0397T ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP), WITH OPTICAL

ENDOMICROSCOPY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0398T MAGNETIC RESONANCE IMAGE GUIDED HIGH INTENSITY FOCUSED ULTRASOUND (MRGFUS), STEREOTACTIC ABLATION LESION, INTRACRANIAL FOR MOVEMENT DISORDER INCLUDING

STEREOTACTIC NAVIGATION AND FRAME PLACEMENT WHEN PERFORMED

0399T MYOCARDIAL STRAIN IMAGING (QUANTITATIVE ASSESSMENT OF MYOCARDIAL MECHANICS USING IMAGE-BASED ANALYSIS OF LOCAL MYOCARDIAL DYNAMICS) (LIST SEPARATELY IN

ADDITION TO CODE FOR PRIMARY PROCEDURE)

0400T MULTI-SPECTRAL DIGITAL SKIN LESION ANALYSIS OF CLINICALLY ATYPICAL CUTANEOUS PIGMENTED LESIONS FOR DETECTION OF MELANOMAS AND HIGH RISK MELANOCYTIC ATYPIA;

ONE TO FIVE LESIONS

0401T MULTI-SPECTRAL DIGITAL SKIN LESION ANALYSIS OF CLINICALLY ATYPICAL CUTANEOUS PIGMENTED LESIONS FOR DETECTION OF MELANOMAS AND HIGH RISK MELANOCYTIC ATYPIA;

SIX OR MORE LESIONS

0402T COLLAGEN CROSS-LINKING OF CORNEA (INCLUDING REMOVAL OF THE CORNEAL EPITHELIUM AND INTRAOPERATIVE PACHYMETRY WHEN PERFORMED)

0404T TRANSCERVICAL UTERINE FIBROID(S) ABLATION WITH ULTRASOUND GUIDANCE, RADIOFREQUENCY

0406T NASAL ENDOSCOPY, SURGICAL, ETHMOID SINUS, PLACEMENT OF DRUG ELUTING IMPLANT;

0407T NASAL ENDOSCOPY, SURGICAL, ETHMOID SINUS, PLACEMENT OF DRUG ELUTING IMPLANT; WITH BIOPSY, POLYPECTOMY OR DEBRIDEMENT

0408T INSERTION OR REPLACEMENT OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM, INCLUDING CONTRACTILITY EVALUATION WHEN PERFORMED, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; PULSE GENERATOR WITH TRANSVENOUS ELECTRODES

0409T INSERTION OR REPLACEMENT OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM, INCLUDING CONTRACTILITY EVALUATION WHEN PERFORMED, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; PULSE GENERATOR ONLY

0410T INSERTION OR REPLACEMENT OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM, INCLUDING CONTRACTILITY EVALUATION WHEN PERFORMED, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; ATRIAL ELECTRODE ONLY

 

0411T INSERTION OR REPLACEMENT OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM, INCLUDING CONTRACTILITY EVALUATION WHEN PERFORMED, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; VENTRICULAR ELECTRODE ONLY

0412T REMOVAL OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM; PULSE GENERATOR

ONLY

0413T REMOVAL OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM; TRANSVENOUS ELECTRODE (ATRIAL OR VENTRICULAR)

0414T REMOVAL AND REPLACEMENT OF PERMANENT CARDIAC CONTRACTILITY MODULATION SYSTEM PULSE GENERATOR ONLY

0415T REPOSITIONING OF PREVIOUSLY IMPLANTED CARDIAC CONTRACTILITY MODULATION TRANSVENOUS ELECTRODE (ATRIAL OR VENTRICULAR LEAD)

0416T RELOCATION OF SKIN POCKET FOR IMPLANTED CARDIAC CONTRACTILITY MODULATION PULSE

GENERATOR

0417T PROGRAMMING DEVICE EVALUATION (IN PERSON) WITH ITERATIVE ADJUSTMENT OF THE IMPLANTABLE DEVICE TO TEST THE FUNCTION OF THE DEVICE AND SELECT OPTIMAL PERMANENT

PROGRAMMED VALUES WITH ANALYSIS, INCLUDING REVIEW AND REPORT, IMPLANTABLE CARDIAC CONTRACTILITY MODULATION SYSTEM

0418T INTERROGATION DEVICE EVALUATION (IN PERSON) WITH ANALYSIS, REVIEW AND REPORT,

INCLUDES CONNECTION, RECORDING AND DISCONNECTION PER PATIENT ENCOUNTER, IMPLANTABLE CARDIAC CONTRACTILITY MODULATION SYSTEM

0419T DESTRUCTION OF NEUROFIBROMA, EXTENSIVE (CUTANEOUS, DERMAL EXTENDING INTO

SUBCUTANEOUS); FACE, HEAD AND NECK, GREATER THAN 50 NEUROFIBROMAS

0420T DESTRUCTION OF NEUROFIBROMA, EXTENSIVE (CUTANEOUS, DERMAL EXTENDING INTO SUBCUTANEOUS); TRUNK AND EXTREMITIES, EXTENSIVE, GREATER THAN 100 NEUROFIBROMAS

0422T TACTILE BREAST IMAGING BY COMPUTER-AIDED TACTILE SENSORS, UNILATERAL OR BILATERAL

0423T SECRETORY TYPE II PHOSPHOLIPASE A2 (SPLA2-IIA)

0424T INSERTION OR REPLACEMENT OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; COMPLETE SYSTEM (TRANSVENOUS PLACEMENT OF RIGHT OR LEFT STIMULATION LEAD, SENSING LEAD, IMPLANTABLE PULSE GENERATOR)

0425T INSERTION OR REPLACEMENT OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; SENSING LEAD ONLY

0426T INSERTION OR REPLACEMENT OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL

SLEEP APNEA; STIMULATION LEAD ONLY

0427T INSERTION OR REPLACEMENT OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; PULSE GENERATOR ONLY

0428T REMOVAL OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; PULSE GENERATOR ONLY

0429T REMOVAL OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; SENSING LEAD ONLY

0430T REMOVAL OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA;

STIMULATION LEAD ONLY

0431T REMOVAL AND REPLACEMENT OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA, PULSE GENERATOR ONLY

0432T REPOSITIONING OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA; STIMULATION LEAD ONLY

0433T REPOSITIONING OF NEUROSTIMULATOR SYSTEM FOR TREATMENT OF CENTRAL SLEEP APNEA;

SENSING LEAD ONLY

0434T INTERROGATION DEVICE EVALUATION IMPLANTED NEUROSTIMULATOR PULSE GENERATOR SYSTEM FOR CENTRAL SLEEP APNEA

0435T PROGRAMMING DEVICE EVALUATION OF IMPLANTED NEUROSTIMULATOR PULSE GENERATOR SYSTEM FOR CENTRAL SLEEP APNEA; SINGLE SESSION

0436T PROGRAMMING DEVICE EVALUATION OF IMPLANTED NEUROSTIMULATOR PULSE GENERATOR SYSTEM FOR CENTRAL SLEEP APNEA; DURING SLEEP STUDY

0437T IMPLANTATION OF NON-BIOLOGIC OR SYNTHETIC IMPLANT (EG, POLYPROPYLENE) FOR FASCIAL

REINFORCEMENT OF THE ABDOMINAL WALL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0439T MYOCARDIAL CONTRAST PERFUSION ECHOCARDIOGRAPHY, AT REST OR WITH STRESS, FOR

ASSESSMENT OF MYOCARDIAL ISCHEMIA OR VIABILITY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0440T ABLATION, PERCUTANEOUS, CRYOABLATION, INCLUDES IMAGING GUIDANCE; UPPER EXTREMITY

DISTAL/PERIPHERAL NERVE

 

0441T ABLATION, PERCUTANEOUS, CRYOABLATION, INCLUDES IMAGING GUIDANCE; LOWER EXTREMITY DISTAL/PERIPHERAL NERVE

0442T ABLATION, PERCUTANEOUS, CRYOABLATION, INCLUDES IMAGING GUIDANCE; NERVE PLEXUS OR OTHER TRUNCAL NERVE (EG, BRACHIAL PLEXUS, PUDENDAL NERVE)

0443T REAL-TIME SPECTRAL ANALYSIS OF PROSTATE TISSUE BY FLUORESCENCE SPECTROSCOPY, INCLUDING IMAGING GUIDANCE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0444T INITIAL PLACEMENT OF A DRUG-ELUTING OCULAR INSERT UNDER ONE OR MORE EYELIDS, INCLUDING FITTING, TRAINING, AND INSERTION, UNILATERAL OR BILATERAL

0445T SUBSEQUENT PLACEMENT OF A DRUG-ELUTING OCULAR INSERT UNDER ONE OR MORE EYELIDS, INCLUDING RE-TRAINING, AND REMOVAL OF EXISTING INSERT, UNILATERAL OR BILATERAL

0446T CREATION OF SUBCUTANEOUS POCKET WITH INSERTION OF IMPLANTABLE INTERSTITIAL

GLUCOSE SENSOR, INCLUDING SYSTEM ACTIVATION AND PATIENT TRAINING

0447T REMOVAL OF IMPLANTABLE INTERSTITIAL GLUCOSE SENSOR FROM SUBCUTANEOUS POCKET VIA INCISION

0448T REMOVAL OF IMPLANTABLE INTERSTITIAL GLUCOSE SENSOR WITH CREATION OF SUBCUTANEOUS POCKET AT DIFFERENT ANATOMIC SITE AND INSERTION OF NEW IMPLANTABLE SENSOR, INCLUDING SYSTEM ACTIVATION

0449T INSERTION OF AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, INTERNAL APPROACH, INTO THE SUBCONJUNCTIVAL SPACE; INITIAL DEVICE

0450T INSERTION OF AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, INTERNAL APPROACH, INTO THE SUBCONJUNCTIVAL SPACE; EACH ADDITIONAL DEVICE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0453T INSERTION OR REPLACEMENT OF A PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, ENDOVASCULAR APPROACH, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; MECHANO-ELECTRICAL SKIN INTERFACE

0454T INSERTION OR REPLACEMENT OF A PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, ENDOVASCULAR APPROACH, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; SUBCUTANEOUS ELECTRODE

0457T REMOVAL OF PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM; MECHANO-ELECTRICAL SKIN INTERFACE

0458T REMOVAL OF PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST

SYSTEM; SUBCUTANEOUS ELECTRODE

0460T REPOSITIONING OF PREVIOUSLY IMPLANTED AORTIC COUNTERPULSATION VENTRICULAR ASSIST DEVICE; SUBCUTANEOUS ELECTRODE

0462T PROGRAMMING DEVICE EVALUATION (IN PERSON) WITH ITERATIVE ADJUSTMENT OF THE IMPLANTABLE MECHANO-ELECTRICAL SKIN INTERFACE AND/OR EXTERNAL DRIVER TO TEST THE FUNCTION OF THE DEVICE AND SELECT OPTIMAL PERMANENT PROGRAMMED VALUES WITH

ANALYSIS, INCLUDING REVIEW AND REPORT, IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, PER DAY

0463T INTERROGATION DEVICE EVALUATION (IN PERSON) WITH ANALYSIS, REVIEW AND REPORT,

INCLUDES CONNECTION, RECORDING AND DISCONNECTION PER PATIENT ENCOUNTER, IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, PER DAY

0464T VISUAL EVOKED POTENTIAL, TESTING FOR GLAUCOMA, WITH INTERPRETATION AND REPORT

0465T SUPRACHOROIDAL INJECTION OF A PHARMACOLOGIC AGENT (DOES NOT INCLUDE SUPPLY OF MEDICATION)

0466T INSERTION OF CHEST WALL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE ARRAY,

INCLUDING CONNECTION TO PULSE GENERATOR (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0467T REVISION OR REPLACEMENT OF CHEST WALL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE

ARRAY, INCLUDING CONNECTION TO EXISTING PULSE GENERATOR

0468T REMOVAL OF CHEST WALL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE ARRAY

 

 

Group 2 Paragraph: Procedures for Part A only Group 2 Codes:

 

 

Group 3 Paragraph:

 

Procedures for Part B only

 

*Additional information beyond code descriptor J0275* Alprostadil urethral suppository (Muse)

Group 3 Codes:

01990 PHYSIOLOGICAL SUPPORT FOR HARVESTING OF ORGAN(S) FROM BRAIN-DEAD PATIENT

15820 BLEPHAROPLASTY, LOWER EYELID;

15821 BLEPHAROPLASTY, LOWER EYELID; WITH EXTENSIVE HERNIATED FAT PAD

15824 RHYTIDECTOMY; FOREHEAD

15825 RHYTIDECTOMY; NECK WITH PLATYSMAL TIGHTENING (PLATYSMAL FLAP, P-FLAP)

15826 RHYTIDECTOMY; GLABELLAR FROWN LINES

15828 RHYTIDECTOMY; CHEEK, CHIN, AND NECK

15829 RHYTIDECTOMY; SUPERFICIAL MUSCULOAPONEUROTIC SYSTEM (SMAS) FLAP

15876 SUCTION ASSISTED LIPECTOMY; HEAD AND NECK

15877 SUCTION ASSISTED LIPECTOMY; TRUNK

15878 SUCTION ASSISTED LIPECTOMY; UPPER EXTREMITY

15879 SUCTION ASSISTED LIPECTOMY; LOWER EXTREMITY

17380 ELECTROLYSIS EPILATION, EACH 30 MINUTES

19105 ABLATION, CRYOSURGICAL, OF FIBROADENOMA, INCLUDING ULTRASOUND GUIDANCE, EACH FIBROADENOMA

22857 TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, INCLUDING DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION), SINGLE INTERSPACE, LUMBAR

22858 TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, INCLUDING DISCECTOMY WITH END PLATE PREPARATION (INCLUDES OSTEOPHYTECTOMY FOR NERVE ROOT OR SPINAL CORD DECOMPRESSION AND MICRODISSECTION); SECOND LEVEL, CERVICAL (LIST SEPARATELY

IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

22862 REVISION INCLUDING REPLACEMENT OF TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, SINGLE INTERSPACE; LUMBAR

22865 REMOVAL OF TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, SINGLE INTERSPACE; LUMBAR

28890 EXTRACORPOREAL SHOCK WAVE, HIGH ENERGY, PERFORMED BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, REQUIRING ANESTHESIA OTHER THAN LOCAL, INCLUDING ULTRASOUND GUIDANCE, INVOLVING THE PLANTAR FASCIA

29868 ARTHROSCOPY, KNEE, SURGICAL; MENISCAL TRANSPLANTATION (INCLUDES ARTHROTOMY FOR MENISCAL INSERTION), MEDIAL OR LATERAL

33477 TRANSCATHETER PULMONARY VALVE IMPLANTATION, PERCUTANEOUS APPROACH, INCLUDING

PRE-STENTING OF THE VALVE DELIVERY SITE, WHEN PERFORMED

58321 ARTIFICIAL INSEMINATION; INTRA-CERVICAL

58322 ARTIFICIAL INSEMINATION; INTRA-UTERINE

58323 SPERM WASHING FOR ARTIFICIAL INSEMINATION

58670 LAPAROSCOPY, SURGICAL; WITH FULGURATION OF OVIDUCTS (WITH OR WITHOUT TRANSECTION)

58671 LAPAROSCOPY, SURGICAL; WITH OCCLUSION OF OVIDUCTS BY DEVICE (EG, BAND, CLIP, OR FALOPE RING)

58970 FOLLICLE PUNCTURE FOR OOCYTE RETRIEVAL, ANY METHOD

58974 EMBRYO TRANSFER, INTRAUTERINE

58976 GAMETE, ZYGOTE, OR EMBRYO INTRAFALLOPIAN TRANSFER, ANY METHOD

59012 CORDOCENTESIS (INTRAUTERINE), ANY METHOD

65785 IMPLANTATION OF INTRASTROMAL CORNEAL RING SEGMENTS

89250 CULTURE OF OOCYTE(S)/EMBRYO(S), LESS THAN 4 DAYS;

89251 CULTURE OF OOCYTE(S)/EMBRYO(S), LESS THAN 4 DAYS; WITH CO-CULTURE OF OOCYTE(S)/EMBRYOS

89253 ASSISTED EMBRYO HATCHING, MICROTECHNIQUES (ANY METHOD)

89254 OOCYTE IDENTIFICATION FROM FOLLICULAR FLUID

89255 PREPARATION OF EMBRYO FOR TRANSFER (ANY METHOD)

89257 SPERM IDENTIFICATION FROM ASPIRATION (OTHER THAN SEMINAL FLUID)

89258 CRYOPRESERVATION; EMBRYO(S)

89259 CRYOPRESERVATION; SPERM

89260 SPERM ISOLATION; SIMPLE PREP (EG, SPERM WASH AND SWIM-UP) FOR INSEMINATION OR DIAGNOSIS WITH SEMEN ANALYSIS

 

89261 SPERM ISOLATION; COMPLEX PREP (EG, PERCOLL GRADIENT, ALBUMIN GRADIENT) FOR INSEMINATION OR DIAGNOSIS WITH SEMEN ANALYSIS

89264 SPERM IDENTIFICATION FROM TESTIS TISSUE, FRESH OR CRYOPRESERVED

89268 INSEMINATION OF OOCYTES

89272 EXTENDED CULTURE OF OOCYTE(S)/EMBRYO(S), 4-7 DAYS

89280 ASSISTED OOCYTE FERTILIZATION, MICROTECHNIQUE; LESS THAN OR EQUAL TO 10 OOCYTES

89281 ASSISTED OOCYTE FERTILIZATION, MICROTECHNIQUE; GREATER THAN 10 OOCYTES

89290 BIOPSY, OOCYTE POLAR BODY OR EMBRYO BLASTOMERE, MICROTECHNIQUE (FOR PRE- IMPLANTATION GENETIC DIAGNOSIS); LESS THAN OR EQUAL TO 5 EMBRYOS

89291 BIOPSY, OOCYTE POLAR BODY OR EMBRYO BLASTOMERE, MICROTECHNIQUE (FOR PRE- IMPLANTATION GENETIC DIAGNOSIS); GREATER THAN 5 EMBRYOS

89335 CRYOPRESERVATION, REPRODUCTIVE TISSUE, TESTICULAR

89337 CRYOPRESERVATION, MATURE OOCYTE(S)

89342 STORAGE (PER YEAR); EMBRYO(S)

89343 STORAGE (PER YEAR); SPERM/SEMEN

89344 STORAGE (PER YEAR); REPRODUCTIVE TISSUE, TESTICULAR/OVARIAN

89346 STORAGE (PER YEAR); OOCYTE(S)

89352 THAWING OF CRYOPRESERVED; EMBRYO(S)

89353 THAWING OF CRYOPRESERVED; SPERM/SEMEN, EACH ALIQUOT

89354 THAWING OF CRYOPRESERVED; REPRODUCTIVE TISSUE, TESTICULAR/OVARIAN

89356 THAWING OF CRYOPRESERVED; OOCYTES, EACH ALIQUOT

90476 ADENOVIRUS VACCINE, TYPE 4, LIVE, FOR ORAL USE

90477 ADENOVIRUS VACCINE, TYPE 7, LIVE, FOR ORAL USE

90581 ANTHRAX VACCINE, FOR SUBCUTANEOUS OR INTRAMUSCULAR USE

90585 BACILLUS CALMETTE-GUERIN VACCINE (BCG) FOR TUBERCULOSIS, LIVE, FOR PERCUTANEOUS USE

90632 HEPATITIS A VACCINE (HEPA), ADULT DOSAGE, FOR INTRAMUSCULAR USE

90633 HEPATITIS A VACCINE (HEPA), PEDIATRIC/ADOLESCENT DOSAGE-2 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90634 HEPATITIS A VACCINE (HEPA), PEDIATRIC/ADOLESCENT DOSAGE-3 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90647 HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB), PRP-OMP CONJUGATE, 3 DOSE SCHEDULE,

FOR INTRAMUSCULAR USE

90648 HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB), PRP-T CONJUGATE, 4 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90649 HUMAN PAPILLOMAVIRUS VACCINE, TYPES 6, 11, 16, 18, QUADRIVALENT (4VHPV), 3 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

90680 ROTAVIRUS VACCINE, PENTAVALENT (RV5), 3 DOSE SCHEDULE, LIVE, FOR ORAL USE

90690 TYPHOID VACCINE, LIVE, ORAL

90691 TYPHOID VACCINE, VI CAPSULAR POLYSACCHARIDE (VICPS), FOR INTRAMUSCULAR USE

90849 MULTIPLE-FAMILY GROUP PSYCHOTHERAPY

92970 CARDIOASSIST-METHOD OF CIRCULATORY ASSIST; INTERNAL

92971 CARDIOASSIST-METHOD OF CIRCULATORY ASSIST; EXTERNAL

92997 PERCUTANEOUS TRANSLUMINAL PULMONARY ARTERY BALLOON ANGIOPLASTY; SINGLE VESSEL

92998 PERCUTANEOUS TRANSLUMINAL PULMONARY ARTERY BALLOON ANGIOPLASTY; EACH ADDITIONAL VESSEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

94014 PATIENT-INITIATED SPIROMETRIC RECORDING PER 30-DAY PERIOD OF TIME; INCLUDES REINFORCED EDUCATION, TRANSMISSION OF SPIROMETRIC TRACING, DATA CAPTURE, ANALYSIS

OF TRANSMITTED DATA, PERIODIC RECALIBRATION AND REVIEW AND INTERPRETATION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

94015 PATIENT-INITIATED SPIROMETRIC RECORDING PER 30-DAY PERIOD OF TIME; RECORDING (INCLUDES HOOK-UP, REINFORCED EDUCATION, DATA TRANSMISSION, DATA CAPTURE, TREND

ANALYSIS, AND PERIODIC RECALIBRATION)

94016 PATIENT-INITIATED SPIROMETRIC RECORDING PER 30-DAY PERIOD OF TIME; REVIEW AND INTERPRETATION ONLY BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL

95831 MUSCLE TESTING, MANUAL (SEPARATE PROCEDURE) WITH REPORT; EXTREMITY (EXCLUDING

HAND) OR TRUNK

95832 MUSCLE TESTING, MANUAL (SEPARATE PROCEDURE) WITH REPORT; HAND, WITH OR WITHOUT COMPARISON WITH NORMAL SIDE

95833 MUSCLE TESTING, MANUAL (SEPARATE PROCEDURE) WITH REPORT; TOTAL EVALUATION OF BODY, EXCLUDING HANDS

 

95834 MUSCLE TESTING, MANUAL (SEPARATE PROCEDURE) WITH REPORT; TOTAL EVALUATION OF BODY, INCLUDING HANDS

95851 RANGE OF MOTION MEASUREMENTS AND REPORT (SEPARATE PROCEDURE); EACH EXTREMITY (EXCLUDING HAND) OR EACH TRUNK SECTION (SPINE)

95852 RANGE OF MOTION MEASUREMENTS AND REPORT (SEPARATE PROCEDURE); HAND, WITH OR WITHOUT COMPARISON WITH NORMAL SIDE

96931 REFLECTANCE CONFOCAL MICROSCOPY (RCM) FOR CELLULAR AND SUB-CELLULAR IMAGING OF SKIN; IMAGE ACQUISITION AND INTERPRETATION AND REPORT, FIRST LESION

97545 WORK HARDENING/CONDITIONING; INITIAL 2 HOURS

97546 WORK HARDENING/CONDITIONING; EACH ADDITIONAL HOUR (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

J3530 NASAL VACCINE INHALATION

0058T CRYOPRESERVATION; REPRODUCTIVE TISSUE, OVARIAN

0095T REMOVAL OF TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, EACH

ADDITIONAL INTERSPACE, CERVICAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0098T REVISION INCLUDING REPLACEMENT OF TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC),

ANTERIOR APPROACH, EACH ADDITIONAL INTERSPACE, CERVICAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0101T EXTRACORPOREAL SHOCK WAVE INVOLVING MUSCULOSKELETAL SYSTEM, NOT OTHERWISE

SPECIFIED, HIGH ENERGY

0102T EXTRACORPOREAL SHOCK WAVE, HIGH ENERGY, PERFORMED BY A PHYSICIAN, REQUIRING ANESTHESIA OTHER THAN LOCAL, INVOLVING LATERAL HUMERAL EPICONDYLE

0106T QUANTITATIVE SENSORY TESTING (QST), TESTING AND INTERPRETATION PER EXTREMITY; USING TOUCH PRESSURE STIMULI TO ASSESS LARGE DIAMETER SENSATION

0107T QUANTITATIVE SENSORY TESTING (QST), TESTING AND INTERPRETATION PER EXTREMITY; USING VIBRATION STIMULI TO ASSESS LARGE DIAMETER FIBER SENSATION

0108T QUANTITATIVE SENSORY TESTING (QST), TESTING AND INTERPRETATION PER EXTREMITY; USING

COOLING STIMULI TO ASSESS SMALL NERVE FIBER SENSATION AND HYPERALGESIA

0109T QUANTITATIVE SENSORY TESTING (QST), TESTING AND INTERPRETATION PER EXTREMITY; USING HEAT-PAIN STIMULI TO ASSESS SMALL NERVE FIBER SENSATION AND HYPERALGESIA

0110T QUANTITATIVE SENSORY TESTING (QST), TESTING AND INTERPRETATION PER EXTREMITY; USING OTHER STIMULI TO ASSESS SENSATION

0126T COMMON CAROTID INTIMA-MEDIA THICKNESS (IMT) STUDY FOR EVALUATION OF

ATHEROSCLEROTIC BURDEN OR CORONARY HEART DISEASE RISK FACTOR ASSESSMENT

0163T TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, INCLUDING DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION), EACH ADDITIONAL INTERSPACE,

LUMBAR (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0164T REMOVAL OF TOTAL DISC ARTHROPLASTY, (ARTIFICIAL DISC), ANTERIOR APPROACH, EACH ADDITIONAL INTERSPACE, LUMBAR (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY

PROCEDURE)

0165T REVISION INCLUDING REPLACEMENT OF TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, EACH ADDITIONAL INTERSPACE, LUMBAR (LIST SEPARATELY IN ADDITION

TO CODE FOR PRIMARY PROCEDURE)

0174T COMPUTER-AIDED DETECTION (CAD) (COMPUTER ALGORITHM ANALYSIS OF DIGITAL IMAGE DATA FOR LESION DETECTION) WITH FURTHER PHYSICIAN REVIEW FOR INTERPRETATION AND REPORT, WITH OR WITHOUT DIGITIZATION OF FILM RADIOGRAPHIC IMAGES, CHEST RADIOGRAPH(S),

PERFORMED CONCURRENT WITH PRIMARY INTERPRETATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)

0175T COMPUTER-AIDED DETECTION (CAD) (COMPUTER ALGORITHM ANALYSIS OF DIGITAL IMAGE DATA FOR LESION DETECTION) WITH FURTHER PHYSICIAN REVIEW FOR INTERPRETATION AND REPORT, WITH OR WITHOUT DIGITIZATION OF FILM RADIOGRAPHIC IMAGES, CHEST RADIOGRAPH(S),

PERFORMED REMOTE FROM PRIMARY INTERPRETATION

0202T POSTERIOR VERTEBRAL JOINT(S) ARTHROPLASTY (EG, FACET JOINT[S] REPLACEMENT), INCLUDING FACETECTOMY, LAMINECTOMY, FORAMINOTOMY, AND VERTEBRAL COLUMN FIXATION,

INJECTION OF BONE CEMENT, WHEN PERFORMED, INCLUDING FLUOROSCOPY, SINGLE LEVEL, LUMBAR SPINE

0329T MONITORING OF INTRAOCULAR PRESSURE FOR 24 HOURS OR LONGER, UNILATERAL OR

BILATERAL, WITH INTERPRETATION AND REPORT

0357T CRYOPRESERVATION; IMMATURE OOCYTE(S)

0375T TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, INCLUDING DISCECTOMY

 

 WITH END PLATE PREPARATION (INCLUDES OSTEOPHYTECTOMY FOR NERVE ROOT OR SPINAL CORD DECOMPRESSION AND MICRODISSECTION), CERVICAL, THREE OR MORE LEVELS

0403T PREVENTIVE BEHAVIOR CHANGE, INTENSIVE PROGRAM OF PREVENTION OF DIABETES USING A STANDARDIZED DIABETES PREVENTION PROGRAM CURRICULUM, PROVIDED TO INDIVIDUALS IN

A GROUP SETTING, MINIMUM 60 MINUTES, PER DAY

0405T OVERSIGHT OF THE CARE OF AN EXTRACORPOREAL LIVER ASSIST SYSTEM PATIENT REQUIRING REVIEW OF STATUS, REVIEW OF LABORATORIES AND OTHER STUDIES, AND REVISION OF

ORDERS AND LIVER ASSIST CARE PLAN (AS APPROPRIATE), WITHIN A CALENDAR MONTH, 30 MINUTES OR MORE OF NON-FACE-TO-FACE TIME

0451T INSERTION OR REPLACEMENT OF A PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, ENDOVASCULAR APPROACH, AND PROGRAMMING OF SENSING AND THERAPEUTIC PARAMETERS; COMPLETE SYSTEM (COUNTERPULSATION DEVICE, VASCULAR

GRAFT, IMPLANTABLE VASCULAR HEMOSTATIC SEAL, MECHANO-ELECTRICAL SKIN INTERFACE AND SUBCUTANEOUS ELECTRODES)

0452T INSERTION OR REPLACEMENT OF A PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST SYSTEM, ENDOVASCULAR APPROACH, AND PROGRAMMING OF SENSING

AND THERAPEUTIC PARAMETERS; AORTIC COUNTERPULSATION DEVICE AND VASCULAR HEMOSTATIC SEAL

0455T REMOVAL OF PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST

SYSTEM; COMPLETE SYSTEM (AORTIC COUNTERPULSATION DEVICE, VASCULAR HEMOSTATIC SEAL, MECHANO-ELECTRICAL SKIN INTERFACE AND ELECTRODES)

0456T REMOVAL OF PERMANENTLY IMPLANTABLE AORTIC COUNTERPULSATION VENTRICULAR ASSIST

SYSTEM; AORTIC COUNTERPULSATION DEVICE AND VASCULAR HEMOSTATIC SEAL

0459T RELOCATION OF SKIN POCKET WITH REPLACEMENT OF IMPLANTED AORTIC COUNTERPULSATION VENTRICULAR ASSIST DEVICE, MECHANO-ELECTRICAL SKIN INTERFACE AND ELECTRODES

0461T REPOSITIONING OF PREVIOUSLY IMPLANTED AORTIC COUNTERPULSATION VENTRICULAR ASSIST DEVICE; AORTIC COUNTERPULSATION DEVICE

0493T NEAR-INFRARED SPECTROSCOPY STUDIES OF LOWER EXTREMITY WOUNDS (EG, FOR

OXYHEMOGLOBIN MEASUREMENT)

 

Group 4 Paragraph: Unlisted Procedure Codes

Procedures for Part A and Part B

 

17999+ Unlisted code for Extracorporeal shockwave for integumentary wound healing, high energy, including topical application and dressing care; initial wound

 

17999+ Unlisted code for Extracorporeal shockwave for integumentary wound healing, high energy, including topical application and dressing care; each additional wound (List separately in addition to code for primary procedure)

 

19499+ Unlisted code for Destruction/reduction of malignant breast tumor with externally applied focused microwave, including interstitial placement of disposable catheter with combined temperature monitoring probe and microwave focusing sensocatheter under ultrasound thermotherapy guidance

 

22899+ Unlisted code for Arthrodesis, pre-sacral interbody technique, including disc space preparation, discectomy, with posterior instrumentation, with image guidance, includes bone graft, when performed, lumbar, L4-L5 interspace (List separately in addition to code for primary procedure)

 

22899+ XClose® Tissue Repair System

 

33999+ Unlisted code for Insertion of left atrial hemodynamic monitor; complete system, includes implanted communication module and pressure sensor lead in left atrium including transseptal access, radiological supervision and interpretation, and associated injection procedures, when performed

 

33999+ Unlisted code for Insertion of left atrial hemodynamic monitor; pressure sensor lead at time of insertion of pacing cardioverter-defibrillator pulse generator including radiological supervision and interpretation and associated injection procedures, when performed (List separately in addition to code for primary procedure)

 

33999+ Unlisted code for Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation when performed and intra-operative interrogation and

 

programming when performed; complete system (includes device and electrode)

 

33999+ Unlisted code for Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation when performed and intra-operative interrogation and programming when performed; electrode

 

33999+ Unlisted code for Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation when performed and intra-operative interrogation and programming when performed; device only

 

33999+ Unlisted code for Removal of intracardiac ischemia monitoring device 42299+ Palatal implants (Pillar™)

43659+ Laparoscopic, implantation, replacement, revision, or removal of gastric stimulation electrodes, less curvature

 

43659+ Laporotomy, implantation, replacement, revision, or removal of gastric stimulation electrodes, less curvature

 

45999+* Unlisted procedure, rectum (stapled transanal rectal resection [STARR])

 

46999+ Unlisted procedure, for delivery of thermal energy to the muscle of the anal canal (e.g., for fecal incontinence)

 

47399+ Irreversible electroporation (e.g., NanoKnife System) - surgical ablation of soft tissue of the liver; other unlisted codes should be submitted based on the anatomical location performed

 

64999+ Percutaneous neuromodulation using a percutaneous electrode array (PEA) (eg, BioWave)

 

64999+ Percutaneous or open implantation of neurostimulator electrode array(s), subcutaneous (peripheral subcutaneous field stimulation), including imaging guidance, when performed, cervical, thoracic or lumbar; for trial, including removal at the conclusion of trial period

 

64999+ Percutaneous or open implantation of neurostimulator electrode array(s), subcutaneous (peripheral subcutaneous field stimulation), including imaging guidance, when performed, cervical, thoracic or lumbar; permanent, with implantation of a pulse generator

 

64999+ Revision or removal of pulse generator or electrodes, including imaging guidance, when performed, including addition of new electrodes, when performed

 

64999+ Electronic analysis of implanted peripheral subcutaneous field stimulation pulse generator, with reprogramming when performed

 

78999+ Intraoperative nuclear mapping during parathyroidectomy (Gamma probe) 84999+ Holotranscobalamin, quantitative

84999+ Lipoprotein, direct measurement, intermediate density lipoproteins (IDL) (remnant lipoproteins) 84999+ Neuronal thread protein (NTP)

88749 Skin advanced glycation endproducts (AGE) measurement by multi-wavelength fluorescent spectroscopy (Skin testing for diabetes)

 

92700+ Vestibular evoked myogenic potentials (VEMP) 93799+ Acoustic ECG analysis

93799+ Unlisted code for Programming device evaluation (in person) of intracardiac ischemia monitoring system with iterative adjustment of programmed values, with analysis, review, and report

 

93799+ Unlisted code for Interrogation device evaluation (in person) of intracardiac ischemia monitoring system with analysis, review, and report

 

94799+ Diagnostic evaluation and measurement of bronchial wheeze rate 95999+ Tremor measurement with accelerometer(s) and/or gyroscope(s)

95999+ Unlisted code for Motor function mapping using non-invasive navigated transcranial magnetic stimulation (nTMS) for therapeutic treatment planning, upper and lower extremity

 

97039+ Cold laser therapy (low level laser therapy) 97139+ MicroVas® therapy

97799+ (Vertebral Axial Decompression/Intervertebral Differential Dynamics) (i.e., treatment which “combines

pelvic and/or cervical traction connected to a special table that permits the traction application"; any similar device would fall under this category of a non-covered benefit. Therapeutic Tables (e.g., VAX-D, Decompression Reduction Stabilization (DRS) System, Accu-Spina System, DRX-3000, DRX9000, SpineMED Decompression Table, and Lordex Traction Unit) are used for this service and are motorized traction devices used to stretch the lower back.

 

99199+ Multivariate analysis of patient specific findings with quantifiable computer probability assessment, including report

Group 4 Codes:

22899 UNLISTED PROCEDURE, SPINE

 

Group 5 Paragraph: Procedures for Part B only

01999+ Regional intravenous administration of local

anesthetic agent or other medication (upper or lower extremity)

 

20999+ Extracorporeal shock wave involving musculoskeletal system, not otherwise specified, low energy

 

22899+ Arthroscopic laser arthrodesis/rhizotomy of the facet joint with cancellous bone allograph and autologous platelet gel patch

 

22899+ Epiduroscopy/Myeloscopy 27599+ Tidal knee irrigation

30999+ Rhinophototherapy, intranasal application of ultraviolet and visible light 33999+ Abdominal aorta transplant from a cadaver

44799+ Endoscope, retrograde imaging/illumination colonoscopic device (implantable); e.g. Third Eye Retroscope® (physician services only)

 

53899+ Treatment(s) for incontinence, pulsed magnetic neuromodulation, per day 58999GY+ Pap plus speculoscopy (PPS)

58999+ Speculoscopy

 

58999+ Speculoscopy, with directed sampling

 

64999+ Blood Brain Barrier Disruption (BBBD) (See National Noncoverage Decisions for Blood Brain Barrier Disruption (BBBD) for Treatment of Brain Tumors)

 

64999+ Bretylium Bier Block 64999+ Fetal Tissue Transplantation 64999+ Nucleoplasty

66999+ Deep Sclerectomy with or without Collagen Implant

 

66999+ Fistulization of sclera for glaucoma, through ciliary body

 

67299+ Destruction of localized lesion of choroid (eg, choroidal neovascularization), transpupillary thermotherapy 67299+ Destruction of macular drusen, photocoagulation

68399+ Conjunctival incision with posterior extrascleral placement of pharmacological agent (does not include supply of medication)

 

68899+ Balloon Lacrimoplasty

 

76499+ Electrical impedance scan of the breast, bilateral (risk assessment device for breast cancer)

 

76499+ MRI for use in measuring the blood flow, spectroscopy imaging of cortical bone and calcification, and procedures involving resolution of bone or calcification

 

76499+ Dual energy x-ray absorptiometry [DEXA] body composition study, one or more sites

 

76499+ Unlisted code for Near-infrared guidance for vascular access requiring real-time digital visualization of subcutaneous vasculature for evaluation of potential access sites and vessel patency

 

78699+ SPECT with Altropane for early diagnosis of Parkinson’s Disease 86849+ Zstat flu influenza test kits

89240+ Epiluminescense microscopy

 

89240+ In-vitro chemosensitivity and/or resistance assays 92700+ Electrical stimulation for the treatment of dysphagia 92700GY+ Politzer procedure

93799+ Inert gas rebreathing for cardiac output measurement; during rest

 

93799+ Inert gas rebreathing for cardiac output measurement; during exercise 93799+ Metaidobenzylquanidine (MIBG) imaging

93799+ Pulsemetric Dynapulse System (for use as an electrical thoracic bioimpedance device)

 

93799+* Unlisted cardiovascular service or procedure (CardioMEMS™) 94799+ Pulmonary rehabilitation program

95199+ Adoptive Immunotherapy

 

95999+ Biothesiometry

95999+ Surface electromyography 97799+ Matrix Pro elect/DT

99199+ Validated, statistically reliable, randomized, controlled, single-patient clinical investigation of FDA approved chronic care drugs, provided by a pharmacist, interpretation and report to the prescribing health care professional

 

99199+ End diastolic pneumatic compression therapy (Circulator Boot) using a heart monitor; segmental and nonsegmental compression of the leg (for the treatment of ulcers) in the office setting

 

99199+ Intravenous lidocaine for chronic pain 99199+ Light reflecting rheography

 

E1399GY+ Disposable pain control infusion pump (PCIP) J3490+ Becaplermin (Regranex)

J3490+ Shark Cartilage Injections

 

Note: The above list of noncovered services is not all inclusive.

 

*Codes that contain additional information beyond the CPT descriptor.

 

+Claims for these services will always be reviewed, as they must currently be billed with an unlisted procedure code.

 

++Covered if beneficiary is enrolled in an approved category B investigational device exemption (IDE) study.

 

++Covered if meets CMS coverage with evidence development (CED) criteria

 

GY Item or service statutorily excluded, does not meet the definition of any Medicare benefit or, for non-Medicare insurers, is not a contract benefit.

 

Group 5 Codes:

01999 UNLISTED ANESTHESIA PROCEDURE(S)

 

 

IC      D-10 Codes that Support Medical Necessity Group 1 Paragraph: N/A

Group 1 Codes:

ICD-10 Codes Description

XX000 Not Applicable

 

 

ICD-10 Codes that DO NOT Support Medical Necessity

Additional ICD-10 Information N/A

General Information

As      sociated Information Documentation Requirements

 

In order for a noncovered service/procedure listed in this LCD to be evaluated for coverage, a reconsideration request to remove the service/procedure from the list must be submitted in writing to the medical policy department. Copies of published evidence (e.g., peer-reviewed medical literature, published studies, etc.) must also be included with the reconsideration request.

 

Utilization Guidelines

 

N/A

Sources of Information

First Coast Service Options, Inc., reference LCD number(s) – L29023, L29288, L29398

 

Sources of Information and Basis for Decision for all items and services included as noncovered in this LCD can be located at the link below listed under “Related Documents”.

 

Social Security Act Title XVIII Section 1862 (a)(1) and Section 1879.

 

Other Contractors

 

Bibliography

 

N/A

 

Revision History Information

Revision

History Date Revision

History Number

Revision History Explanation

Reason(s) for Change

03/08/2018 R27 Revision Number: 16

Publication: March 2018 Connection LCR A/B2018-026

 

Explanation of revision:  Based on an LCD reconsideration, this LCD was revised to remove CPT code 55874 from the “CPT/HCPCS Codes – Group 1 Codes:” under the subtitle “Procedures for Part A and Part B” section of the LCD and HCPCS code L8699 (Prosthetic implant, not otherwise specified [when used for hydrogel application of a spacer to increase the distance between the prostate and anterior rectal wall]) from the “CPT/HCPCS Codes – Group 5 Paragraph/Codes:” under the subtitle “Procedures for Part B only” section of the LCD. The effective date of this revision is based on date of service.

 

03/08/2018: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore

not all the fields included on the LCD are applicable as noted in this policy. • Reconsideration Request

01/18/2018 R26 Revision Number: 15

Publication: January 2018 Connection LCR A/B2018-013

 

Explanation of revision: The “Sources of Information and Basis for Decision” was updated to include multiple published sources from reconsideration requests received in 2017 for CPT codes 0449T and 0450T (insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space). The content of the LCD has not been changed in response to the reconsideration requests. The effective date of this revision is based on date of service.

 

01/18/2018: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore

not all the fields included on the LCD are applicable as noted in this policy. • Reconsideration Request

01/01/2018 R25 Revision Number: 14

Publication: December 2017 Connection LCR A/B2018-001

 

Explanation of revision: Annual 2018 HCPCS Update. CPT codes 0293T, 0294T, 0302 T, 0303T, 0304T and 0307T

were deleted and replaced with unlisted code

33999+, CPT codes 0299T and 0300T were deleted and • Revisions Due To CPT/HCPCS Code Changes

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

 replaced with unlisted code 17999+, CPT code 0301T was deleted and replaced with unlisted code 19499+, CPT codes 0305T and 0306T were deleted and replaced with unlisted code 93799+, CPT code 0309T was deleted and replaced with unlisted code 22899, and CPT code 0310T was deleted and replaced with unlisted code 95999+.

These unlisted codes were added in the “CPT/HCPCS Codes – Group 4 Paragraph:” under the subtitle “Procedures for Part A and Part B” section of the

LCD. Also, CPT code 0340T was deleted  and replaced with CPT code 32994, CPT code 0348T was deleted and replaced with CPT code 55874, and CPT codes 34806, 87470, 87477, 87515, and 93982 were deleted in the “CPT/HCPCS Codes – Group 1 Codes:” under the subtitle “Procedures for Part A and Part B” section of the LCD. In addition, unlisted code 76499+ for transcutaneous oxyhemoglobin measurement in a lower extremity wound by near-infrared spectroscopy was deleted and replaced with CPT Code 0493T in the “CPT/HCPCS Codes – Group 3 Codes:” under the subtitle “Procedures for Part B only” section of the LCD and the descriptors for CPT codes 0333T, 90620, and 90621 were revised in the “CPT/HCPCS Codes” under the subtitle “Procedures for Part A and Part B” section of the LCD. The effective date of this revision is based on date of service. Furthermore, based on CR 10117 (National Coverage Determination [NCD20.8.4]: Leadless Pacemakers), the LCD was revised to remove Category III CPT codes 0387T, 0389T, 0390T, and 0391T from the “CPT/HCPCS Codes – Group 1 Paragraph:” under the subtitle “Procedures for Part A and Part B” section of the LCD. The effective date of this revision is for claims processed on or after 01/02/2018, for dates of service on or after 01/18/2017. Also, based on CR 10236 (October 2017 Update of the Hospital Outpatient Prospective Payment System [OPPS]), CPT code 0421T was moved from “CPT/HCPCS Codes – Group 3 Codes:” under the subtitle “Procedures for Part B only” section of the LCD to “CPT/HCPCS Codes – Group 1 Codes:” under the subtitle “Procedures for Part A and Part B” section of the LCD with the symbol "++" to indicate it is covered if the beneficiary is enrolled in an approved category B investigational device exemption (IDE) study. The effective date of this revision is for claims processed on or after 01/01/2018, for dates of service on or after 06/05/2017. In addition, CPT code 0329T was moved from “CPT/HCPCS Codes – Group 1 Codes:” under the subtitle “Procedures for Part A and Part B” section of the LCD to “CPT/HCPCS Codes – Group 3 Codes:” under the subtitle “Procedures for Part B only” section of the LCD as this code has a Part A status indicator “E1” (Noncovered). The effective date of this revision is for claims processed on or after 01/01/2018.

 

01/01/2018: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore not all the fields included on the LCD are applicable as

noted in this policy.

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

11/30/2017 R24 November 2017

Related approved article for "Sources of Information and Basis for Decision" effective on November 30, 2017. • Reconsideration Request

11/30/2017 R23 Revision Number: 13

Publication: December 2017 Connection LCR A/B2017-050

 

Explanation of revision: The “Sources of Information and Basis for Decision” was updated to include 15 published sources from previous reconsideration requests (received in July 2015 and October 2016) for HCPCS/CPT Codes C9737/43284/43285/43289 for magnetic band augmentation of the lower esophageal sphincter (LINX). The content of the LCD has not been changed in response to the reconsideration requests. The effective date of this revision is based on date of service.

 

11/30/2017: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore

not all the fields included on the LCD are applicable as noted in this policy. • Reconsideration Request

11/13/2017 R22 November 2017

Related Coding Guideline Article to Noncovered Services LCD. • Provider Education/Guidance

11/13/2017 R21 Revision Number: 12

Publication: November 2017 Connection LCR A/B2017-047

 

Explanation of revision:  Based on an LCD reconsideration, this LCD was revised to remove CPT code 84145 [Procalcitonin (PCT)] from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and Part B”. In addition, “Sources of Information and Basis for Decision” was updated with 15 full text published sources from a reconsideration request for Category III codes 0466T, 0467T and 0468T for the Inspire® Hypoglossal Nerve Stimulation system for the treatment of Obstructive Sleep Apnea. The content of the LCD has not been changed in response to the reconsideration request. The effective date of this revision is based on date of service.

 

11/13/2017: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination and therefore not all the fields included on the LCD are applicable as

noted in this policy. • Reconsideration Request

07/24/2017 R20 Revision Number: 11

Publication: June 2017 Connection LCR A/B2017-024

 

Explanation of revision: The Medical Policy and Procedures Department evaluated the following services and determined that they are not considered medically

reasonable and necessary at this time based on current available published evidence (e.g., peer-reviewed medical • Provider Education/Guidance

• New/Updated Technology

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

  literature, and published studies). Therefore, Category III CPT codes 0446T - 0448T, 0449T - 0450T, 0453T -0454T, 0457T-0458T, 0460T, 0462T-0464T, 0466T – 0468T and

CPT code 64568 Incision for implantation of cranial nerve (e.g., vagus nerve) neurostimulator electrode array and pulse generator [when specified as implantation of hypoglossal nerve stimulator] have been added to the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and Part B.) and Category III CPT codes 0451T-0452T, 0455T-0456T, 0459T, and 0461T

have been added to the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part B only”. The effective date of this revision is for dates of service on or after 07/24/2017. Also, based on the

Decision Memo for Leadless Pacemakers (CAG-00448N) , the following clarifying language (++Covered if meets CMS coverage with evidence development (CED) criteria) was added in the “CPT/HCPCS Codes” section of the LCD related to Category III CPT codes 0387T, 0388T, 0389T, 0390T, and 0391T. The effective date of this revision is for claims processed on or after 07/24/2017, for dates of service on or after 01/18/2017. In addition, based on CR 8776, the following language was removed from the “CPT/HCPCS Codes” section of the LCD: “Per CR 8572, beginning in CY 2014, payment for most laboratory tests (except for molecular pathology tests) will be packaged under the OPPS, therefore the clinical laboratory tests listed below, for TOB 13X (outpatient hospital), are packaged in this setting.” The effective date of this

revision is for claims processed on or after 05/12/2017, for dates of service on or after 01/01/2014.

05/01/2017 R19 Revision Number: 10

Publication: March 2017 Connection LCR A/B2017-013

 

Explanation of revision: The Medical Policy and Procedures Department evaluated the following services and determined that they are not considered medically reasonable and necessary at this time based on current available published evidence (e.g., peer-reviewed medical literature, and published studies). Therefore, CPT Category III codes 0437T, 0438T, 0439T, 0440T, 0441T,

0442T, 0443T, 0444T, and 0445T have been added to the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and Part B”. Additionally, HCPCS code L8699 (Prosthetic implant, not otherwise specified [when used for hydrogel application of a spacer to increase the distance between the prostate and anterior rectal wall]) has been added to the “Unlisted Procedure Codes” section of the LCD under the subtitle “Procedures for Part B only”. The effective date of this revision is based on date of service. Additionally, CPT code 84999+ [Cancer Type ID], was removed from the “Unlisted Procedure Codes” section of the LCD under “Part A and Part B” and will be given individual consideration. The effective date of these revisions is for claims processed on

or after 03/27/2017, for dates of service or after 04/01/2015. • Revisions Due To ICD-10-CM Code Changes

• Revisions Due To CPT/HCPCS Code Changes

01/01/2017 R18 Revision Number: 9 • Revisions Due To

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

  Publication: December 2016 Connection LCR A/B2017-001

 

Explanation of Revision: Based on the Annual 2017 HCPCS Update CR9752 the following Category III CPT codes were deleted: CPT code 0019T was deleted and replaced with unlisted code 20999+. CPT code 0336T was deleted and replaced with CPT code 58674. CPT codes 0392T and 0393T were deleted and replaced with 43284 and 43285 respectively. CPT unlisted code 67299+ was deleted and replaced with 0465T. In Addition, CPT codes 0282T, 0283T, 0284T, 0285T were deleted and replaced with CPT unlisted code 64999+, CPT codes 0286T and 0287T were deleted and replaced with CPT unlisted code 76499+ and CPT code 0288T was deleted and replaced with unlisted code 46999+. Also, CPT codes 0291T, 0292T and unlisted code 43289+ (Unlisted laparoscopy procedure, esophagus (LINX® reflux management system) were deleted. In addition, descriptor was revised for CPT codes 0274T and 90644. Based on CR9892 Category III CPT code 0398T was deleted from the “Procedures for Part B only” section and added to the

“Procedures for Part A and Part B” section of the LCD. The effective date of this revision is based on date of service. CPT/HCPCS Code Changes

10/31/2016 R17 Revision Number: 8

Publication: September 2016 Connection LCR A/B2016-098

 

Explanation of revision: Based on a reconsideration request this LCD was revised to remove CPT code 97610 from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Listed Procedure Codes/Procedures for Part A and Part B”. The effective date of this revision is for dates of service on or after 10/06/2016. In addition, based on the creation of a new LCD (Prostatic Urethral Lift

#L36775), this LCD was revised to remove HCPCS codes C9739 and C9740 from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Listed Procedure Codes/Procedures for Part A and Part B”, CPT codes 52441 and 52442 from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Listed Procedure Codes/Procedures for Part B only”, and HCPCS code L8699 (Prosthetic implant, not otherwise specified [when used for the transprostatic urethral lift implant]) from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Unlisted Procedure Codes/Procedures for Part B only”.

The effective date of this revision is for dates of service on or after 10/31/16. • Other

10/31/2016 R16 Revision Number: 8

Publication: September 2016 Connection LCR A/B2016-098

 

Explanation of revision: Based on a reconsideration request this LCD was revised to remove CPT code 97610 from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and Part B” The effective date of this revision is for dates of service on or

after 10/06/2016. In addition, based on the creation of a new LCD (Prostatic Urethral Lift #L36775), this LCD was • Provider Education/Guidance

• Public Education/Guidance

• Reconsideration Request

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

  revised to remove HCPCS codes C9739 and C9740 from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and Part B.” Additional codes removed were CPT codes 52441 and 52442 from the “CPT/HCPCS Codes” section of the LCD under the

subtitle “Procedures for Part B only.” The effective date of this revision is for dates of service on or after 10/31/16.

07/25/2016 R15 Revision Number: 7

Publication: July 2016 Connection LCR A/B2016-083

 

Explanation of revision: This LCD was revised to remove CPT code 0405T from the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part A and “Procedures for Part B and add CPT code 0405T to the “CPT/HCPCS Codes” section of the LCD under the subtitle “Procedures for Part B only” as the OPPS payment status indicator is a “B” (Not paid under OPPS).” The effective

date of this revision is for claims processed on or after 7/25/16, for dates of service on or after 01/01/16. • Revisions Due To CPT/HCPCS Code Changes

07/25/2016 R14 Revision Number: 5

Publication: June 2016 Connection LCR A/B2016-068

 

Explanation of revision: The Medical Policy and Procedures Department evaluated the following services and determined that they are not considered medically reasonable and necessary at this time based on current available published evidence (e.g., peer-reviewed medical literature, and published studies) Therefore, CPT® codes 96931 – 96936, CPT Category III codes 0396T, 0397T,

and 0399T- 0436T have been added to the LCD The effective date of this revision is based on date of service. Additionally, CPT 88375-Optical microscopic image(s), interpretation and report has been deleted based on a prior revision removing associated services (CPT codes 43206 and 43252) for claims processed on or after 04/16/2016 for date of service on or after 12/21/2015. In

addition, the formatting of the LCD was revised to remove duplicity of coding. • Provider Education/Guidance

• Public Education/Guidance

02/15/2016 R13 Revision Number: 4 Publication: N/A LCR A/B2016-034

 

Explanation of revision: Based on an LCD reconsideration request, this LCD was revised to remove CPT code 0100T (placement of a subconjunctival retinal prosthesis receiver and pulse generator, and implantation of intra-ocular retinal electrode array, with vitrectomy) from the “CPT/HCPCS Codes” section of the LCD under the subtitle

“Procedures for Part B.” The effective date of this revision is based on date of service. • Reconsideration Request

02/09/2016 R12 Revision Number: 4 Publication: N/A LCR A/B2016-034

 

Explanation of revision: Based on an LCD reconsideration request, this LCD was revised to remove CPT code 0100T (placement of a subconjunctival retinal prosthesis receiver • Reconsideration Request

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

  and pulse generator, and implantation of intra-ocular retinal electrode array, with vitrectomy) from the “CPT/HCPCS Codes” section of the LCD under the subtitle

“Procedures for Part B.” The effective date of this revision is based on date of service.

01/21/2016 R11 HCPCS update; Descriptor change for CPT 90644 • Revisions Due To CPT/HCPCS Code

Changes

01/21/2016 R10 Revision History Number R8 contains a typographical error. HCPCS codes listed as G0627 and G0628 should be

HCPCS codes G6027 and G6028. The effective date of this revision is for dates of service on or after 01/01/16. • Typographical Error

01/21/2016 R9 Revision Number: 3

Publication: January 2016 Connection LCR A/B2016-023

 

Explanation of revision: Based on an LCD reconsideration request, this LCD was revised to remove CPT code 0008M from the “CPT/HCPCS Codes” section of the LCD under the subtitles “Laboratory Procedures for Part A” and “Laboratory Procedures for Part B.” CPT code 0008M (Oncology (breast), mRNA analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (FFPE) tissue, prognostic algorithm reported as a risk score) will be added to the Gene Expression Profiling Panel for use in the Management of Breast Cancer Treatment LCD (L33586) with limited coverage

indications. The effective date of this revision is based on date of service. • Reconsideration Request

01/01/2016 R8 Revision Number: 2

Publication: December 2015 Connection LCR A/B2016-017

 

Explanation of Revision: Based on the annual 2016 HCPCS Update the following Category III CPT codes were deleted: CPT code 0099T was deleted and replaced with CPT code 65785, CPT code 0103T was deleted and replaced with unlisted CPT code 84999, CPT code 0123T was deleted and replaced with unlisted CPT code 66999, CPT code 0223T, 0224T, and 0225T were deleted and replaced with unlisted CPT code 93799, CPT code 0233T was deleted and replaced with unlisted CPT code 88749, CPT code 0243T and 0244T were deleted and replaced with unlisted CPT code 94799, CPT code 0262T was deleted and replaced with CPT code 33477, and 0311T was deleted and replaced with CPT code 93050. The following Category I codes were deleted: HCPCS codes G0627 and G0628 were deleted and replaced with 46601 and 46607 and unlisted CPT code 20999 for Magnetic resonance guided focused ultrasound surgery (MRgFUS) (e.g., ExAblate) has been deleted and replaced with Category III code 0398T. CPT codes 90645, 90646, 90692, and 90693 were deleted. In addition, the descriptor was revised on the following CPT codes 87320, 90632, 90633, 90634, 90644, 90647, 90648, 90649,

90650, 90680, 90681, and 0358T. The effective date of this revision is for dates of service on or after 01/01/16.

 

Also, the LCD was revised to remove CPT code 95806 • New/Updated Technology

 

Revision History Date Revision History Number

Revision History Explanation

Reason(s) for Change

  from the “CPT/HCPCS Codes” section of the LCD under the subtitles “Procedures for Part A” and “Procedures for Part B” and to remove CPT code 95803 from the CPT/HCPCS Codes” section of the LCD under the subtitles “Procedures for Part B”. CPT codes 95803 and 95806 were added to the Polysomnography and Sleep Testing LCD (L33405). In addition, the LCD was revised to remove CPT codes 43206 and 43252 from the “CPT/HCPCS Codes” section of the LCD under the subtitles “Procedures for Part A” and “Procedures for Part B.” The

effective date of this revision is for dates of service on or after 12/21/2015.

11/22/2015 R7 Revision Number: 1

Publication: November 2015 Connection LCR A/B2015-032

 

Explanation of revision: This LCD was revised to remove CPT code 0330T from the “CPT/HCPCS Codes” section of the LCD under the subtitles “Procedures for Part A” and “Procedures for Part B.” CPT code 0330T (Tear film imaging, unilateral or bilateral, with interpretation and report) will be added to the Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease

(DED) LCD (L36232) as a noncovered service. The effective date of this revision is based on date of service. • Revisions Due To CPT/HCPCS Code Changes

10/01/2015 R6 09/21/2015 The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD’s language and coding. • Provider Education/Guidance

10/01/2015 R5 06/08/2015- - The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD’s language and coding. • Provider Education/Guidance

10/01/2015 R4 5/29/2015-The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD’s language and coding. • Provider Education/Guidance

10/01/2015 R3 10/23/2014: The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD’s language and coding. • Revisions Due To ICD-10-CM Code Changes

10/01/2015 R2 10/20/14: The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD’s language and coding. • Revisions Due To ICD-10-CM Code Changes

10/01/2015 R1 05/29/2014 – The language and/or ICD-10-CM diagnoses were updated to be consistent with current LCD language and ICD-9-CM coding. • Provider Education/Guidance

• Revisions Due To

ICD-10-CM Code

Changes